BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vellingiri B, Jayaramayya K, Iyer M, Narayanasamy A, Govindasamy V, Giridharan B, Ganesan S, Venugopal A, Venkatesan D, Ganesan H, Rajagopalan K, Rahman PKSM, Cho SG, Kumar NS, Subramaniam MD. COVID-19: A promising cure for the global panic. Sci Total Environ 2020;725:138277. [PMID: 32278175 DOI: 10.1016/j.scitotenv.2020.138277] [Cited by in Crossref: 334] [Cited by in F6Publishing: 361] [Article Influence: 167.0] [Reference Citation Analysis]
Number Citing Articles
1 Singh KN, Mantri JK. Classifications of COVID-19 Variants Using Rough Set Theory. Smart Innovation, Systems and Technologies 2023. [DOI: 10.1007/978-981-19-6068-0_37] [Reference Citation Analysis]
2 Sivaranjanee R, Senthil Kumar P, Rangasamy G. Endurance of COVID 19 in wastewater, natural prescription and antiviral medication for the analysis of COVID 19 and its effects on the development of new antiseptic strategies. Total Environment Research Themes 2022;3-4:100010. [DOI: 10.1016/j.totert.2022.100010] [Reference Citation Analysis]
3 Nerkar AG, Badar S. Ethnopharmacological review of kalmegh for anticancer activity. CTPPC 2022;4:152-157. [DOI: 10.18231/j.ctppc.2022.027] [Reference Citation Analysis]
4 Jamal QMS. Antiviral Potential of Plants against COVID-19 during Outbreaks—An Update. IJMS 2022;23:13564. [DOI: 10.3390/ijms232113564] [Reference Citation Analysis]
5 G G, A S V, Dhama K. Angiotensin Converting Enzyme 2 (ACE2) - A macromolecule and its impact on human reproduction during COVID-19 pandemic. J Exp Bio & Ag Sci 2022;10:960-977. [DOI: 10.18006/2022.10(5).960.977] [Reference Citation Analysis]
6 Córdoba-tovar L, Barón PAR, Marrugo-negrete J, Roa-fuentes LL, Jonathan M. Scientific production on medicinal plants and their efficacy against Covid-19: A review and scientometric analysis based on VOSviewer. Acta Ecologica Sinica 2022. [DOI: 10.1016/j.chnaes.2022.10.005] [Reference Citation Analysis]
7 de Matos PH, da Silva TP, Mansano AB, Gancedo NC, Tonin FS, Pelloso FC, Petruco MV, de Melo EB, Fernandez-llimos F, Sanches ACC, de Mello JCP, Chierrito D, de Medeiros Araújo DC. Bioactive compounds as potential angiotensin-converting enzyme II inhibitors against COVID-19: a scoping review. Inflamm Res 2022. [DOI: 10.1007/s00011-022-01642-7] [Reference Citation Analysis]
8 Balogun TA, Chukwudozie OS, Ogbodo UC, Junaid IO, Sunday OA, Ige OM, Aborode AT, Akintayo AD, Oluwarotimi EA, Oluwafemi IO, Saibu OA, Chuckwuemaka P, Omoboyowa DA, Alausa AO, Atasie NH, Ilesanmi A, Dairo G, Tiamiyu ZA, Batiha GE, Alkhuriji AF, Al-megrin WAI, De Waard M, Sabatier J. Discovery of putative inhibitors against main drivers of SARS-CoV-2 infection: Insight from quantum mechanical evaluation and molecular modeling. Front Chem 2022;10:964446. [DOI: 10.3389/fchem.2022.964446] [Reference Citation Analysis]
9 Sarangi MK, Padhi S, Patel LD, Rath G, Nanda SS, Yi DK. Theranostic efficiency of biosurfactants against COVID-19 and similar viruses - A review. J Drug Deliv Sci Technol 2022;76:103764. [PMID: 36090183 DOI: 10.1016/j.jddst.2022.103764] [Reference Citation Analysis]
10 Pisoschi AM, Iordache F, Stanca L, Gajaila I, Ghimpeteanu OM, Geicu OI, Bilteanu L, Serban AI. Antioxidant, Anti-inflammatory, and Immunomodulatory Roles of Nonvitamin Antioxidants in Anti-SARS-CoV-2 Therapy. J Med Chem 2022. [PMID: 36136726 DOI: 10.1021/acs.jmedchem.2c01134] [Reference Citation Analysis]
11 Qayed WS, Ferreira RS, Silva JRA. In Silico Study towards Repositioning of FDA-Approved Drug Candidates for Anticoronaviral Therapy: Molecular Docking, Molecular Dynamics and Binding Free Energy Calculations. Molecules 2022;27:5988. [DOI: 10.3390/molecules27185988] [Reference Citation Analysis]
12 Jeetoo J, Jaunky VC, Imhof JO. Willingness to pay to enhance pandemic preparedness in Mauritius. Public Health 2022;211:144-8. [PMID: 36113200 DOI: 10.1016/j.puhe.2022.07.017] [Reference Citation Analysis]
13 Manikkam R, Parthasarathy K, Baskaran A, Dellibabu L. Inferences of actinobacterial metabolites to combat Corona virus. ADV TRADIT MED (ADTM) 2022. [DOI: 10.1007/s13596-022-00661-3] [Reference Citation Analysis]
14 Santos JALD, Camargo ABD, Lisboa AM, Rocha CCT, Estevam C, Latterza E, Cassiano GP, Paladini RDS, Carneiro TC. Desafios do ensino remoto para crianças e adolescentes com câncer em tempos de pandemia pela COVID-19 no contexto da educação hospitalar: estudo de caso. Revista da Sociedade Brasileira de Enfermeiros Pediatras 2022;22. [DOI: 10.31508/1676-379320220002] [Reference Citation Analysis]
15 Yang F, Jiang X, Tariq A, Sadia S, Ahmed Z, Sardans J, Aleem M, Ullah R, Bussmann RW. Potential medicinal plants involved in inhibiting 3CLpro activity: A practical alternate approach to combating COVID-19. Journal of Integrative Medicine 2022. [DOI: 10.1016/j.joim.2022.08.001] [Reference Citation Analysis]
16 Pardeshi CV, Pardeshi SR, Naik JB, Shirkhedkar AA, Surana SJ. Herbal Bioactives for Treating Respiratory Infections. Herbal Drugs for the Management of Infectious Diseases 2022. [DOI: 10.1002/9781119818779.ch5] [Reference Citation Analysis]
17 Kamyab H, Naderipour A, Jahannoush M, Abdullah A, Marzbali MH. Potential effect of SARS-CoV-2 on solar energy generation: Environmental dynamics and implications. Sustainable Energy Technologies and Assessments 2022;52:102027. [DOI: 10.1016/j.seta.2022.102027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Dogancı MA, Ay Sal F, Guler HI, Katı H, Ceylan E, Belduz AO, Bozdal G, Yaylı N, Canakcı S. Investigation of potential inhibitor properties of violacein against HIV-1 RT and CoV-2 Spike RBD:ACE-2. World J Microbiol Biotechnol 2022;38:161. [PMID: 35834025 DOI: 10.1007/s11274-022-03350-0] [Reference Citation Analysis]
19 Nawal A, Shoaib M, Zámečník R, Rehman AU. Effects of Occupational Stress, Self-Efficacy and Mental Health During the Pandemic on Hospital Sanitation Workers in Malaysia. Eval Health Prof 2022;:1632787221112079. [PMID: 35794858 DOI: 10.1177/01632787221112079] [Reference Citation Analysis]
20 Şen Doğan R, Deveci Şirin H. Death anxiety and satisfaction with life among the adults in the social isolation process of Covid-19 pandemic: the mediating role of perceived stress. J Ment Health 2022;:1-10. [PMID: 35770825 DOI: 10.1080/09638237.2022.2069689] [Reference Citation Analysis]
21 Kurrey R, Saha A. An Overview of SARS-CoV-2 and Technologies for Detection and Ongoing Treatments: A Human Safety Initiative. COVID 2022;2:731-51. [DOI: 10.3390/covid2060055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Kanwar VS, Sharma A, Rinku, Kanwar M, Srivastav AL, Soni DK. An overview for biomedical waste management during pandemic like COVID-19. Int J Environ Sci Technol . [DOI: 10.1007/s13762-022-04287-5] [Reference Citation Analysis]
23 İnce Köse T, Gençler Özkan AM. ANTIVIRAL HERBS. Ankara Ecz Fak Derg 2022;46:505-522. [DOI: 10.33483/jfpau.1057473] [Reference Citation Analysis]
24 Kobbaey T, Bilquise G, Alqatawna J, Dashti O. A Blockchain-based Vaccination Model for COVID-19 and Other Infectious Diseases. 2022 8th International Conference on Information Technology Trends (ITT) 2022. [DOI: 10.1109/itt56123.2022.9863942] [Reference Citation Analysis]
25 Kesheh MM, Shavandi S, Haeri Moghaddam N, Ramezani M, Ramezani F. Effect of herbal compounds on coronavirus; a systematic review and meta-analysis. Virol J 2022;19:87. [PMID: 35597998 DOI: 10.1186/s12985-022-01808-z] [Reference Citation Analysis]
26 Xu J, Zhou Z, Chen K, Ding Y, Hua Y, Ren M, Shen Y. How to minimize the impact of COVID-19 on laparoendoscopic single-site surgery training? ANZ J Surg 2022. [PMID: 35594058 DOI: 10.1111/ans.17819] [Reference Citation Analysis]
27 Hoang M, De S. Worldwide Consequences of COVID-19 on Research in STEM. Adv J Grad Res 2022;12:36-47. [DOI: 10.21467/ajgr.12.1.36-47] [Reference Citation Analysis]
28 Akindele AJ, Sowemimo A, Agunbiade FO, Sofidiya MO, Awodele O, Ade-ademilua O, Orabueze I, Ishola IO, Ayolabi CI, Salu OB, Akinleye MO, Oreagba IA; [ACEDHARS UNILAG COVID-19 Response Team]. Bioprospecting for Anti-COVID-19 Interventions From African Medicinal Plants: A Review. Natural Product Communications 2022;17:1934578X2210969. [DOI: 10.1177/1934578x221096968] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Serrano-Aroca Á. Antiviral Characterization of Advanced Materials: Use of Bacteriophage Phi 6 as Surrogate of Enveloped Viruses Such as SARS-CoV-2. Int J Mol Sci 2022;23:5335. [PMID: 35628148 DOI: 10.3390/ijms23105335] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
30 Goyal R, Bala R, Sindhu RK, Zehravi M, Madaan R, Ramproshad S, Mondal B, Dey A, Rahman MH, Cavalu S. Bioactive Based Nanocarriers for the Treatment of Viral Infections and SARS-CoV-2. Nanomaterials 2022;12:1530. [DOI: 10.3390/nano12091530] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
31 Gandhi Y, Mishra SK, Rawat H, Grewal J, Kumar R, Shakya SK, Jain VK, Babu G, Singh A, Singh R, Acharya R, Kumar V. Phytomedicines Explored under In vitro and In silico Studies against Coronavirus: An Opportunity to Develop Traditional Medicines. South African Journal of Botany 2022. [DOI: 10.1016/j.sajb.2022.04.053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Cyganowski P, Dzimitrowicz A. Heterogenous nanocomposite catalysts with rhenium nanostructures for the catalytic reduction of 4-nitrophenol. Sci Rep 2022;12:6228. [PMID: 35422074 DOI: 10.1038/s41598-022-10237-5] [Reference Citation Analysis]
33 Islam MA, Haque MA, Rahman MA, Hossen F, Reza M, Barua A, Marzan AA, Das T, Kumar Baral S, He C, Ahmed F, Bhattacharya P, Jakariya M. A Review on Measures to Rejuvenate Immune System: Natural Mode of Protection Against Coronavirus Infection. Front Immunol 2022;13:837290. [PMID: 35371007 DOI: 10.3389/fimmu.2022.837290] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
34 Ničkčović VP, Nikolić GR, Nedeljković BM, Mitić N, Danić SF, Mitić J, Marčetić Z, Sokolović D, Veselinović AM. In silico approach for the development of novel antiviral compounds based on SARS-COV-2 protease inhibition. Chem Pap . [DOI: 10.1007/s11696-022-02170-8] [Reference Citation Analysis]
35 Rajaram H, Harshitha N, Ram SA, Patra SM, Niranjan V, Vishnumurthy K. Targeting non-structural proteins and 3CLpro in SARS-CoV-2 virus using phytochemicals from medicinal plants - In-silico approach. Journal of the Indian Chemical Society 2022. [DOI: 10.1016/j.jics.2022.100488] [Reference Citation Analysis]
36 Ferreira LLC, Abreu MP, Costa CB, Leda PO, Behrens MD, Dos Santos EP. Curcumin and Its Analogs as a Therapeutic Strategy in Infections Caused by RNA Genome Viruses. Food Environ Virol 2022. [PMID: 35352306 DOI: 10.1007/s12560-022-09514-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Kar P, Saleh-E-In MM, Jaishee N, Anandraj A, Kormuth E, Vellingiri B, Angione C, Rahman PKSM, Pillay S, Sen A, Naidoo D, Roy A, Choi YE. Computational profiling of natural compounds as promising inhibitors against the spike proteins of SARS-CoV-2 wild-type and the variants of concern, viral cell-entry process, and cytokine storm in COVID-19. J Cell Biochem 2022. [PMID: 35342986 DOI: 10.1002/jcb.30243] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Taube AA. Aspects of the safe use of medicinal products based on medicinal plant materials in COVID-19. MyRWD 2022;2:28-35. [DOI: 10.37489/2782-3784-myrwd-9] [Reference Citation Analysis]
39 Paredes-ramos M, Conde Piñeiro E, Pérez-sánchez H, López-vilariño JM, Alu'datt MH. Evaluation of Natural Peptides to Prevent and Reduce the Novel SARS-CoV-2 Infection. Journal of Food Quality 2022;2022:1-13. [DOI: 10.1155/2022/2102937] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Kamran SM, Khaskhely MK, Nassani AA, Haffar M, Abro MMQ. Social Entrepreneurship Opportunities via Distant Socialization and Social Value Creation. Sustainability 2022;14:3170. [DOI: 10.3390/su14063170] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 Ali F, Alom S, Shakya A, Ghosh SK, Singh UP, Bhat HR. Implication of in silico studies in the search for novel inhibitors against SARS-CoV-2. Arch Pharm (Weinheim) 2022;:e2100360. [PMID: 35244237 DOI: 10.1002/ardp.202100360] [Reference Citation Analysis]
42 Nira, Kumar H. Epidemiological Mucormycosis treatment and diagnosis challenges using the adaptive properties of computer vision techniques based approach: a review. Multimed Tools Appl 2022;81:14217-45. [PMID: 35233180 DOI: 10.1007/s11042-022-12450-w] [Reference Citation Analysis]
43 Ahmed R. Crosstalk between SARS-CoV-2 and Testicular Hemostasis: Perspective View. Biotechnology to Combat COVID-19 2022. [DOI: 10.5772/intechopen.98218] [Reference Citation Analysis]
44 Dixit S, Sharma M. Current Status of COVID-19 Diagnostics. Biotechnology to Combat COVID-19 2022. [DOI: 10.5772/intechopen.96955] [Reference Citation Analysis]
45 Azmi F, Bano H. Respiratory Infectious Disease and the COVID-19 Pandemic : A Review of Medieval Unani Medical Literature. JNR 2022;22:1. [DOI: 10.18311/jnr/2022/26624] [Reference Citation Analysis]
46 Javed A. Neurological Associations of SARS-CoV-2 Infection: A Systematic Review. CNS Neurol Disord Drug Targets 2022;21:246-58. [PMID: 33593267 DOI: 10.2174/1871527320666210216121211] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
47 Khodavirdipour A, Chamanrokh P, Alikhani MY, Alikhani MS. Potential of Bacillus subtilis Against SARS-CoV-2 – A Sustainable Drug Development Perspective. Front Microbiol 2022;13:718786. [DOI: 10.3389/fmicb.2022.718786] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
48 Emamipari F, Kamali S, Nikzad G, Roosta Navi N, Soltani S, Kalani MR, Department of Animal Sciences, College of Life Sciences, Kharazmi University of Tehran, Tehran, Iran, Department of Molecular Cell Biology - Molecular Cell Science, Faculty of Basic Sciences, Mohaghegh Ardabili University, Ardabil, Iran, Department of Molecular Cell Biology - Molecular Cell Science, Faculty of Basic Sciences, Mohaghegh Ardabili University, Ardabil, Iran, Department of Molecular Cell Biology - Molecular Cell Science, Payame Noor University of Talesh, Gilan, Iran, Department of Biology, Shahr-e-Quds Branch, Islamic Azad University, Tehran, Iran, Molecular Medicine Department, Golestan University of Medical Sciences, Gorgan, Iran. A Review of Pleiotropic Potential of Erythropoietin as an Adjunctive Therapy for COVID-19. jcbr 2022;6:11-27. [DOI: 10.52547/jcbr.6.1.11] [Reference Citation Analysis]
49 Alici H, Tahtaci H, Demir K. Design and various in silico studies of the novel curcumin derivatives as potential candidates against COVID-19 -associated main enzymes. Computational Biology and Chemistry 2022. [DOI: 10.1016/j.compbiolchem.2022.107657] [Reference Citation Analysis]
50 Schulte B, König M, Escher BI, Wittenburg S, Proj M, Wolf V, Lemke C, Schnakenburg G, Sosič I, Streeck H, Müller CE, Gütschow M, Steinebach C. Andrographolide Derivatives Target the KEAP1/NRF2 Axis and Possess Potent Anti-SARS-CoV-2 Activity. ChemMedChem 2022;:e202100732. [PMID: 35099120 DOI: 10.1002/cmdc.202100732] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Pasrija R, Naime M. Resolving the equation between mucormycosis and COVID-19 disease. Mol Biol Rep 2022. [PMID: 35064406 DOI: 10.1007/s11033-021-07085-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
52 Mukherjee PK, Efferth T, Das B, Kar A, Ghosh S, Singha S, Debnath P, Sharma N, Bhardwaj PK, Haldar PK. Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications. Phytomedicine 2022;98:153930. [PMID: 35114450 DOI: 10.1016/j.phymed.2022.153930] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
53 Madan S, Sembhi J, Khurana N, Makkar K, Byati P. Yoga for Preventive Health: A Holistic Approach. American Journal of Lifestyle Medicine. [DOI: 10.1177/15598276211059758] [Reference Citation Analysis]
54 Olukolajo MA, Oyetunji AK, Oluleye IB. Covid-19 protocols: assessing construction site workers compliance. JEDT 2022;20:115-31. [DOI: 10.1108/jedt-03-2021-0131] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
55 Kaur R, Singh S, Singh TG, Sood P, Robert J. Covid-19: pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination. Inflammopharmacology 2022. [PMID: 34981320 DOI: 10.1007/s10787-021-00904-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Ribeiro TDS, Stechi G, Castro PCD, Viana AL. Comunicação em saúde sobre COVID-19 e Diabetes Mellitus em mídias sociais: verdadeiro e falso. Esc Anna Nery 2022;26:e20210358. [DOI: 10.1590/2177-9465-ean-2021-0358] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Kesh SS, Palai S. Herbs and drugs in clinical trials for coronavirus treatments. Coronavirus Drug Discovery 2022. [DOI: 10.1016/b978-0-323-95574-4.00001-9] [Reference Citation Analysis]
58 Singh V, Srivastava A, Faheem M. Recent insights of SARS-CoV-2 potential inhibitors. Biomed Biotechnol Res J 2022;6:21. [DOI: 10.4103/bbrj.bbrj_229_21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Vadnere NC, Patil NP. Natural Protease Inhibitors and Their Therapeutic Potentials Against SARS-CoV-2. Natural Products as Enzyme Inhibitors 2022. [DOI: 10.1007/978-981-19-0932-0_9] [Reference Citation Analysis]
60 Cyganowski P, Wolska J. Nanocomposite membranes with Au nanoparticles for dialysis-based catalytic reduction-separation of nitroaromatic compounds. Reactive and Functional Polymers 2022;170:105119. [DOI: 10.1016/j.reactfunctpolym.2021.105119] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Subramaniam MD, Abishek Kumar B, Chirayath RB, Nair AP, Iyer M, Vellingiri B. Environmental Transmission of Human Pathogens Associated with SARS-CoV-2 and the Effect on Soil and Aquatic Ecosystem: A Biological Way of Management. The Handbook of Environmental Chemistry 2022. [DOI: 10.1007/698_2022_849] [Reference Citation Analysis]
62 Paital B, Agrawal PK. Role of environmental factors in transmission of COVID-19. COVID-19 in the Environment 2022. [DOI: 10.1016/b978-0-323-90272-4.00017-8] [Reference Citation Analysis]
63 Chowdhury MNR, Alif YA, Alam S, Emon NU, Richi FT, Zihad SMNK, Taki MTI, Rashid MA. Theoretical effectiveness of steam inhalation against SARS-CoV-2 infection: updates on clinical trials, mechanism of actions, and traditional approaches. Heliyon 2022;8:e08816. [PMID: 35097233 DOI: 10.1016/j.heliyon.2022.e08816] [Reference Citation Analysis]
64 Azeem M, Mustafa G, Mahrosh HS. Virtual screening of phytochemicals by targeting multiple proteins of severe acute respiratory syndrome coronavirus 2: Molecular docking and molecular dynamics simulation studies. Int J Immunopathol Pharmacol 2022;36:039463202211427. [DOI: 10.1177/03946320221142793] [Reference Citation Analysis]
65 Adam GO. Bioactive compounds and herbal preparations implicated in the treatment of SARS-CoV-2. Coronavirus Drug Discovery 2022. [DOI: 10.1016/b978-0-323-95574-4.00006-8] [Reference Citation Analysis]
66 Galati D, Zanotta S, Capitelli L, Bocchino M. A bird's eye view on the role of dendritic cells in SARS-CoV-2 infection: Perspectives for immune-based vaccines. Allergy 2022;77:100-10. [PMID: 34245591 DOI: 10.1111/all.15004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
67 Mtewa AG, Ngwira KJ, Sesaazi DC. Computational demonstration of cheminformatics and machine learning in coronavirus drug discovery. Coronavirus Drug Discovery 2022. [DOI: 10.1016/b978-0-323-95578-2.00009-1] [Reference Citation Analysis]
68 Mtewa AG, Amanjot A, Yadesa TM, Ngwira KJ. Drug repurposing for SARS-CoV-2 (COVID-19) treatment. Coronavirus Drug Discovery 2022. [DOI: 10.1016/b978-0-323-85156-5.00027-4] [Reference Citation Analysis]
69 Poulová P, Klímova B, Nunvarova J. COVID-19 Pandemic and University Students’ Use and Acceptance of Online Learning. Lecture Notes in Computer Science 2022. [DOI: 10.1007/978-3-031-08939-8_22] [Reference Citation Analysis]
70 Zanganeh S, Goodarzi N, Doroudian M, Movahed E. Potential COVID-19 therapeutic approaches targeting angiotensin-converting enzyme 2; An updated review. Rev Med Virol 2021;:e2321. [PMID: 34958163 DOI: 10.1002/rmv.2321] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
71 Zheng ZX. Stem cell therapy: A promising treatment for COVID-19. World J Clin Cases 2021; 9(36): 11148-11155 [DOI: 10.12998/wjcc.v9.i36.11148] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Kshirsagar MM, Dodamani AS, Deokar RN, Garg Y, Khobragade VR, Garg K. Impact of COVID-19 on Dentistry. Int J Clin Pediatr Dent 2021;14:711-4. [PMID: 34934288 DOI: 10.5005/jp-journals-10005-2025] [Reference Citation Analysis]
73 Mehta A, Kumar Ratre Y, Sharma K, Soni VK, Tiwari AK, Singh RP, Dwivedi MK, Chandra V, Prajapati SK, Shukla D, Vishvakarma NK. Interplay of Nutrition and Psychoneuroendocrineimmune Modulation: Relevance for COVID-19 in BRICS Nations. Front Microbiol 2021;12. [DOI: 10.3389/fmicb.2021.769884] [Reference Citation Analysis]
74 Tuncer T, Aydemir E, Özyurt F, Dogan S, Belhaouari SB, Akbal E. An automated Covid-19 respiratory sound classification method based on novel local symmetric Euclidean distance pattern and ReliefF iterative MRMR feature selector. International Advanced Researches and Engineering Journal 2021;5:334-343. [DOI: 10.35860/iarej.898830] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Liu YW, Yang AX, Lu L, Huang TH. Predicting the Molecular Mechanism of Sini Jia Renshen Decoction in Treating Severe COVID-19 Patients Based on Network Pharmacology and Molecular Docking. Natural Product Communications 2021;16:1934578X2110592. [DOI: 10.1177/1934578x211059292] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Bajad NG, Rayala S, Gutti G, Sharma A, Singh M, Kumar A, Singh SK. Systematic review on role of structure based drug design (SBDD) in the identification of anti-viral leads against SARS-Cov-2. Curr Res Pharmacol Drug Discov 2021;2:100026. [PMID: 34870145 DOI: 10.1016/j.crphar.2021.100026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
77 Yu M, Wang DC, Li S, Lei YH, Wei J, Huang LY. Meta-analysis of arbidol versus lopinavir/ritonavir in the treatment of coronavirus disease 2019. J Med Virol 2021. [PMID: 34837230 DOI: 10.1002/jmv.27481] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
78 Arjunan A, Robinson J, Baroutaji A, Tuñón-Molina A, Martí M, Serrano-Aroca Á. 3D Printed Cobalt-Chromium-Molybdenum Porous Superalloy with Superior Antiviral Activity. Int J Mol Sci 2021;22:12721. [PMID: 34884526 DOI: 10.3390/ijms222312721] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
79 Takayama K, Tuñón-Molina A, Cano-Vicent A, Muramoto Y, Noda T, Aparicio-Collado JL, Sabater I Serra R, Martí M, Serrano-Aroca Á. Non-Woven Infection Prevention Fabrics Coated with Biobased Cranberry Extracts Inactivate Enveloped Viruses Such as SARS-CoV-2 and Multidrug-Resistant Bacteria. Int J Mol Sci 2021;22:12719. [PMID: 34884521 DOI: 10.3390/ijms222312719] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
80 Islam F, Bibi S, Meem AFK, Islam MM, Rahaman MS, Bepary S, Rahman MM, Rahman MM, Elzaki A, Kajoak S, Osman H, ElSamani M, Khandaker MU, Idris AM, Emran TB. Natural Bioactive Molecules: An Alternative Approach to the Treatment and Control of COVID-19. Int J Mol Sci 2021;22:12638. [PMID: 34884440 DOI: 10.3390/ijms222312638] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 30.0] [Reference Citation Analysis]
81 Torres Neto L, Monteiro MLG, Galvan D, Conte-Junior CA. An Evaluation of the Potential of Essential Oils against SARS-CoV-2 from In Silico Studies through the Systematic Review Using a Chemometric Approach. Pharmaceuticals (Basel) 2021;14:1138. [PMID: 34832920 DOI: 10.3390/ph14111138] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
82 Artik Y, Cesur N, Kenar L, Ortatatli M. Biological Disasters: In The First Quarter Of 2021 Covid-19 Overview. Afet ve Risk Dergisi. [DOI: 10.35341/afet.977488] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
83 Mungmunpuntipantip R, Wiwanitkit V. Buddhist Monastery, Amulet, Spiritual Support and COVID-19 Outbreak. Anxiety, Uncertainty, and Resilience During the Pandemic Period - Anthropological and Psychological Perspectives 2021. [DOI: 10.5772/intechopen.96496] [Reference Citation Analysis]
84 Khan F, Ansari AN, Nayab M. Rationalistic approach in COVID-19 prevention through intervention of Unani medicine prevalent in epidemic - A review. J Herb Med 2021;30:100515. [PMID: 34722133 DOI: 10.1016/j.hermed.2021.100515] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Demeke CA, Woldeyohanins AE, Kifle ZD. Herbal medicine use for the management of COVID-19: A review article. Metabol Open 2021;12:100141. [PMID: 34693242 DOI: 10.1016/j.metop.2021.100141] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
86 Liu Q, Fung DLX, Lac L, Hu P. A Novel Matrix Profile-Guided Attention LSTM Model for Forecasting COVID-19 Cases in USA. Front Public Health 2021;9:741030. [PMID: 34692627 DOI: 10.3389/fpubh.2021.741030] [Reference Citation Analysis]
87 Guclu G, Al-dulaimi A. Estimating and analyzing the spread of Covid-19 in Turkey using Long Short-Term Memory. 2021 5th International Symposium on Multidisciplinary Studies and Innovative Technologies (ISMSIT) 2021. [DOI: 10.1109/ismsit52890.2021.9604594] [Reference Citation Analysis]
88 da Silva K, Guedes-granzotti RB, Ribeiro VV, Dornelas R, Cruz PJA, César CPHAR. Quality of Life and Sleep Among Brazilian Speech-Language Pathology Students During the COVID-19 Pandemic. Perspect ASHA SIGs 2021;6:1146-1157. [DOI: 10.1044/2021_persp-20-00251] [Reference Citation Analysis]
89 Jha RK, Khan RJ, Parthiban A, Singh E, Jain M, Amera GM, Singh RP, Ramachandran P, Ramachandran R, Sachithanandam V, Muthukumaran J, Singh AK. Identifying the natural compound Catechin from tropical mangrove plants as a potential lead candidate against 3CLpro from SARS-CoV-2: An integrated in silico approach. J Biomol Struct Dyn 2021;:1-20. [PMID: 34644249 DOI: 10.1080/07391102.2021.1988710] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
90 Zaremehrjardi F, Omidi A, Sciortino C, Reid RE, Lukeman R, Hughes JA, Soufan O. Discovering Missing Edges in Drug-Protein Networks: Repurposing Drugs for SARS-CoV-2. 2021 IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB) 2021. [DOI: 10.1109/cibcb49929.2021.9562855] [Reference Citation Analysis]
91 Balkrishna A, Arya V, Rohela A, Kumar A, Verma R, Kumar D, Nepovimova E, Kuca K, Thakur N, Thakur N, Kumar P. Nanotechnology Interventions in the Management of COVID-19: Prevention, Diagnosis and Virus-Like Particle Vaccines. Vaccines (Basel) 2021;9:1129. [PMID: 34696237 DOI: 10.3390/vaccines9101129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
92 Soni S, Namdeo Pudake R, Jain U, Chauhan N. A systematic review on SARS-CoV-2-associated fungal coinfections. J Med Virol 2022;94:99-109. [PMID: 34570905 DOI: 10.1002/jmv.27358] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
93 Umeta Chali B, Melaku T, Berhanu N, Mengistu B, Milkessa G, Mamo G, Alemu S, Mulugeta T. Traditional Medicine Practice in the Context of COVID-19 Pandemic: Community Claim in Jimma Zone, Oromia, Ethiopia. Infect Drug Resist 2021;14:3773-83. [PMID: 34557002 DOI: 10.2147/IDR.S331434] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
94 Bose P, Sunita P, Pattanayak SP. Molecular Insights into the Crosstalk Between Immune Inflammation Nexus and SARS-CoV-2 Virus. Curr Microbiol 2021;78:3813-28. [PMID: 34550435 DOI: 10.1007/s00284-021-02657-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Erukainure OL, Matsabisa MG, Muhammad A, Abarshi MM, Amaku JF, Katsayal SB, Nde AL. Targeting of Protein's Messenger RNA for Viral Replication, Assembly and Release in SARS-CoV-2 Using Whole Genomic Data From South Africa: Therapeutic Potentials of Cannabis Sativa L. Front Pharmacol 2021;12:736511. [PMID: 34539415 DOI: 10.3389/fphar.2021.736511] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
96 Liang S, Leng H, Yuan Q, Yuan C. Impact of the COVID-19 pandemic: Insights from vacation rentals in twelve mega cities. Sustain Cities Soc 2021;74:103121. [PMID: 34540564 DOI: 10.1016/j.scs.2021.103121] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
97 Vassileva S, Mateeva V, Drenovska K. Drug repurposing of dermatologic medications to treat coronavirus disease 2019: Science or fiction? Clin Dermatol 2021;39:430-45. [PMID: 34518001 DOI: 10.1016/j.clindermatol.2021.01.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 Kavane A, Bishoyi AK, Sharma A, Gajbhiye N, Geetha KA. Variability in starch granular morphology of Tinospora cordifolia: an important species of Indian Systems of Medicine (ISM). Vegetos 2021;:1-9. [PMID: 34539104 DOI: 10.1007/s42535-021-00286-y] [Reference Citation Analysis]
99 Alaiya A, Alshukairi A, Shinwari Z, Al-Fares M, Alotaibi J, AlOmaim W, Alsharif I, Bakheet R, Alharbi L, Allam R, Asiri A, Memish Z, Alromaih K, Al-Mozaini M. Alterations in the Plasma Proteome Induced by SARS-CoV-2 and MERS-CoV Reveal Biomarkers for Disease Outcomes for COVID-19 Patients. J Inflamm Res 2021;14:4313-28. [PMID: 34511970 DOI: 10.2147/JIR.S322430] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
100 Laudari HK, Pariyar S, Maraseni T. COVID-19 lockdown and the forestry sector: Insight from Gandaki province of Nepal. For Policy Econ 2021;131:102556. [PMID: 34512124 DOI: 10.1016/j.forpol.2021.102556] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
101 Chumachenko D, Chumachenko T, Bazilevych K, Meniailov I. Forecasting of COVID-19 Epidemic Process by Support Vector Machine Method in Ukraine and Neighboring Countries. 2021 IEEE 2nd KhPI Week on Advanced Technology (KhPIWeek) 2021. [DOI: 10.1109/khpiweek53812.2021.9569968] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Balkrishna A, Tomer M, Verma S, Joshi M, Sharma P, Srivastava J, Varshney A. Phytometabolite profiling of Coronil, a herbal medicine for COVID-19, its identification by mass-spectroscopy and quality validation on liquid chromatographic platforms. J Sep Sci 2021. [PMID: 34510772 DOI: 10.1002/jssc.202100499] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
103 Xiong L, Hu P, Wang H. Establishment of epidemic early warning index system and optimization of infectious disease model: Analysis on monitoring data of public health emergencies. Int J Disaster Risk Reduct 2021;65:102547. [PMID: 34497742 DOI: 10.1016/j.ijdrr.2021.102547] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
104 Bhutta ZA, Kanwal A, Ali M, Kulyar MF, Yao W, Shoaib M, Ashar A, Mahfooz A, Ijaz M, Ijaz N, Asif M, Nawaz S, Mahfooz MR, Kanwal T. Emerging nanotechnology role in the development of innovative solutions against COVID-19 pandemic. Nanotechnology 2021;32. [PMID: 34320471 DOI: 10.1088/1361-6528/ac189e] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
105 Singh R, Goel S, Bourgeade P, Aleya L, Tewari D. Ayurveda Rasayana as antivirals and immunomodulators: potential applications in COVID-19. Environ Sci Pollut Res Int 2021;28:55925-51. [PMID: 34491498 DOI: 10.1007/s11356-021-16280-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
106 Aydin C, Seyidoglu N. Natural Antioxidants to the Rescue? Antioxidants - Benefits, Sources, Mechanisms of Action 2021. [DOI: 10.5772/intechopen.96132] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
107 Rakshit S, Mondal S, Islam N, Jasimuddin S, Zhang Z. Social media and the new product development during COVID-19: An integrated model for SMEs. Technological Forecasting and Social Change 2021;170:120869. [DOI: 10.1016/j.techfore.2021.120869] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
108 Kandari R, Kumar A. COVID-19 pandemic lockdown: effects on the air quality of South Asia. Environmental Sustainability 2021;4:543-9. [DOI: 10.1007/s42398-020-00154-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
109 Tuñón-Molina A, Martí M, Muramoto Y, Noda T, Takayama K, Serrano-Aroca Á. Antimicrobial Face Shield: Next Generation of Facial Protective Equipment against SARS-CoV-2 and Multidrug-Resistant Bacteria. Int J Mol Sci 2021;22:9518. [PMID: 34502431 DOI: 10.3390/ijms22179518] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
110 Salama ME, Suzan AR, Ayat F, Sarah SH, Muhammed RS, Noran MT, Heba M, Mohamed A. Medicinal plant-derived compounds as potential phytotherapy forCOVID-19: Future perspectives. J Pharmacognosy Phytother 2021;13:68-81. [DOI: 10.5897/jpp2021.0603] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
111 bhardwaj P, Godatwar PK, Charan J, Sharma S, Shafi S, Chauhan N, Vyas P, Dutt N, Midha N, Jalandra R, Sharma M, Nag VL, Sharma S, Singh SK, Sharma P, Misra S. Efficacy and Safety of Ayurveda Intervention (AYUSH 64) as add-on therapy for patients with COVID-19 infections – An open labelled, Parallel Group, Randomized controlled clinical trial.. [DOI: 10.1101/2021.08.10.21261836] [Reference Citation Analysis]
112 Tuñón-molina A, Cano-vicent A, Martí M, Muramoto Y, Noda T, Takayama K, Serrano-aroca Á. Next generation infection prevention clothing: Non-woven Fabrics Coated with Cranberry Extracts Capable of Inactivating Enveloped Viruses such as SARS-CoV-2 and Multidrug-resistant Bacteria.. [DOI: 10.1101/2021.08.14.456330] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
113 Ogunrinola OO, Kanmodi RI, Ogunrinola OA. Medicinal plants as immune booster in the palliative management of viral diseases: A perspective on coronavirus. Food Frontiers 2022;3:83-95. [DOI: 10.1002/fft2.107] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
114 Hu F, Wang L, Hu Y, Wang D, Wang W, Jiang J, Li N, Yin P. A novel framework integrating AI model and enzymological experiments promotes identification of SARS-CoV-2 3CL protease inhibitors and activity-based probe. Brief Bioinform 2021:bbab301. [PMID: 34368837 DOI: 10.1093/bib/bbab301] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
115 Amani B, Amani B, Zareei S, Zareei M. Efficacy and safety of arbidol (umifenovir) in patients with COVID-19: A systematic review and meta-analysis. Immun Inflamm Dis 2021. [PMID: 34347937 DOI: 10.1002/iid3.502] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
116 Parthasarathy R, Mathew M, Koshy P, Babu M, Abraham G. Traditional medicines prescribed for prevention of COVID-19: Use with caution. Nephrology (Carlton) 2021. [PMID: 34322937 DOI: 10.1111/nep.13947] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
117 Chen R, Wang T, Song J, Pu D, He D, Li J, Yang J, Li K, Zhong C, Zhang J. Antiviral Drug Delivery System for Enhanced Bioactivity, Better Metabolism and Pharmacokinetic Characteristics. Int J Nanomedicine 2021;16:4959-84. [PMID: 34326637 DOI: 10.2147/IJN.S315705] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
118 Montes-Grajales D, Olivero-Verbel J. Bioinformatics Prediction of SARS-CoV-2 Epitopes as Vaccine Candidates for the Colombian Population. Vaccines (Basel) 2021;9:797. [PMID: 34358213 DOI: 10.3390/vaccines9070797] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
119 Sarangi MK, Padhi S, Dheeman S, Karn SK, Patel LD, Yi DK, Nanda SS. Diagnosis, prevention, and treatment of coronavirus disease: a review. Expert Rev Anti Infect Ther 2021;:1-24. [PMID: 34151679 DOI: 10.1080/14787210.2021.1944103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
120 Dai Y, Zhao Z, Zhou H, Huang D, Luo J, Zhang C, Chen Q, Chen X, Yao Y, Jiang X, Cheng J. Traditional Chinese Medicine Enema Therapy in a Patient With a Confirmed Negative SARS-CoV-2 Test in the Respiratory Tract but Positive in the Intestinal Tract: A Case Report. Front Public Health 2021;9:687283. [PMID: 34307281 DOI: 10.3389/fpubh.2021.687283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 Kumavath R, Barh D, Andrade BS, Imchen M, Aburjaile FF, Ch A, Rodrigues DLN, Tiwari S, Alzahrani KJ, Góes-Neto A, Weener ME, Ghosh P, Azevedo V. The Spike of SARS-CoV-2: Uniqueness and Applications. Front Immunol 2021;12:663912. [PMID: 34305894 DOI: 10.3389/fimmu.2021.663912] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
122 Subramaniam S, Ruf W, Bosmann M. Advocacy of targeting protease-activated receptors in severe coronavirus disease 2019. Br J Pharmacol 2021. [PMID: 34235728 DOI: 10.1111/bph.15587] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
123 Muthumanickam S, Kamaladevi A, Boomi P, Gowrishankar S, Pandian SK. Indian Ethnomedicinal Phytochemicals as Promising Inhibitors of RNA-Binding Domain of SARS-CoV-2 Nucleocapsid Phosphoprotein: An In Silico Study. Front Mol Biosci 2021;8:637329. [PMID: 34277698 DOI: 10.3389/fmolb.2021.637329] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
124 Gonçalves J, Koritnik T, Paragi M. Assessment of weather and atmospheric pollution as a co-factor in the spread of SARS-CoV-2. Acta Biomed 2021;92:e2021094. [PMID: 34212907 DOI: 10.23750/abm.v92i3.11354] [Reference Citation Analysis]
125 Bajaj P, Arya PC. Evolution and spread of SARS-CoV-2 likely to be affected by climate. Climate Change Ecology 2021;1:100005. [DOI: 10.1016/j.ecochg.2021.100005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
126 Selvaraj LK, Thayumanavan G, Jeyabalan S, Jabaris SL. Molecular Docking Studies of Phytoconstituents Identified in Traditional Siddha Polyherbal Formulations Against Possible Targets of SARS-CoV-2. J Mol Docking 2021;1:15-24. [DOI: 10.33084/jmd.v1i1.2264] [Reference Citation Analysis]
127 El-Tanbouly R, Hassan Z, El-Messeiry S. The Role of Indoor Plants in air Purification and Human Health in the Context of COVID-19 Pandemic: A Proposal for a Novel Line of Inquiry. Front Mol Biosci 2021;8:709395. [PMID: 34277711 DOI: 10.3389/fmolb.2021.709395] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
128 Wu MY, Gu M, Leung JK, Li X, Yuan Y, Shen C, Wang L, Zhao E, Chen S. A Membrane-Targeting Photosensitizer with Aggregation-Induced Emission Characteristics for Highly Efficient Photodynamic Combat of Human Coronaviruses. Small 2021;17:e2101770. [PMID: 34190409 DOI: 10.1002/smll.202101770] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 17.0] [Reference Citation Analysis]
129 Abiri R, Abdul-Hamid H, Sytar O, Abiri R, Bezerra de Almeida E Jr, Sharma SK, Bulgakov VP, Arroo RRJ, Malik S. A Brief Overview of Potential Treatments for Viral Diseases Using Natural Plant Compounds: The Case of SARS-Cov. Molecules 2021;26:3868. [PMID: 34202844 DOI: 10.3390/molecules26133868] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
130 Bhattacharya S, Paul SMN. Efficacy of phytochemicals as immunomodulators in managing COVID-19: a comprehensive view. Virusdisease 2021;:1-11. [PMID: 34189187 DOI: 10.1007/s13337-021-00706-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
131 Navabshan I, Sakthivel B, Pandiyan R, Antoniraj MG, Dharmaraj S, Ashokkumar V, Khoo KS, Chew KW, Sugumaran A, Show PL. Computational Lock and Key and Dynamic Trajectory Analysis of Natural Biophors Against COVID-19 Spike Protein to Identify Effective Lead Molecules. Mol Biotechnol 2021. [PMID: 34159564 DOI: 10.1007/s12033-021-00358-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
132 Salisu UO, Akanmu AA, Sanni SM, Fasina SO, Ogunseye NO, Ogunsesan SA, Olatunji MO. COVID-19-related socio-economic impacts and palliative care deliveries during lockdown in Nigeria: a case study. International Journal of Logistics Research and Applications 2021. [DOI: 10.1080/13675567.2021.1939665] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
133 Hasnain A, Hashmi MZ, Bhatti UA, Nadeem B, Wei G, Zha Y, Sheng Y. Assessment of Air Pollution before, during and after the COVID-19 Pandemic Lockdown in Nanjing, China. Atmosphere 2021;12:743. [DOI: 10.3390/atmos12060743] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
134 Balkrishna A, Sharma P, Joshi M, Srivastava J, Varshney A. Development and validation of a rapid high-performance thin-layer chromatographic method for quantification of gallic acid, cinnamic acid, piperine, eugenol, and glycyrrhizin in Divya-Swasari-Vati, an ayurvedic medicine for respiratory ailments. J Sep Sci 2021;44:3146-57. [PMID: 34101986 DOI: 10.1002/jssc.202100096] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
135 Thakar A, Panara K, Patel F, Bhagiya S, Goyal M, Bhinde S, Chaudhari S, Chaturvedi S. Add-on Ayurveda Treatment for Early Stage COVID-19: A Single Center Retrospective Cohort Study From Gujarat, India. J Evid Based Integr Med 2021;26:2515690X211020685. [PMID: 34057365 DOI: 10.1177/2515690X211020685] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
136 Thelwall M. Cures, Treatments and Vaccines for Covid-19: International Differences in Interest on Twitter. Journal of Altmetrics 2021;4. [DOI: 10.29024/joa.42] [Reference Citation Analysis]
137 Sharanya CS, Sabu A, Haridas M. Potent phytochemicals against COVID-19 infection from phyto-materials used as antivirals in complementary medicines: a review. Futur J Pharm Sci 2021;7:113. [PMID: 34095323 DOI: 10.1186/s43094-021-00259-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
138 Wang L, Alexander CA. COVID-19: a pandemic challenging healthcare systems. IISE Transactions on Healthcare Systems Engineering 2021. [DOI: 10.1080/24725579.2021.1933269] [Reference Citation Analysis]
139 Safdar M, Khan MS, Karim AY, Omar SA, Smail SW, Saeed M, Zaheer S, Ali M, Ahmad B, Tasleem M, Junejo Y. SNPs at 3'UTR of APOL1 and miR-6741-3p target sites associated with kidney diseases more susceptible to SARS-COV-2 infection: in silco and in vitro studies. Mamm Genome 2021. [PMID: 34089082 DOI: 10.1007/s00335-021-09880-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
140 Huyut MT, İlkbahar F. The effectiveness of blood routine parameters and some biomarkers as a potential diagnostic tool in the diagnosis and prognosis of Covid-19 disease. Int Immunopharmacol 2021;98:107838. [PMID: 34303274 DOI: 10.1016/j.intimp.2021.107838] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
141 Sharun K, Tiwari R, Dhama K. COVID-19 and sunlight: Impact on SARS-CoV-2 transmissibility, morbidity, and mortality. Ann Med Surg (Lond) 2021;66:102419. [PMID: 34094531 DOI: 10.1016/j.amsu.2021.102419] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
142 Foladori G, Cypher JM. Pandemic Perspectives on Medicine and Militarism. International Critical Thought 2021;11:252-70. [DOI: 10.1080/21598282.2021.1924828] [Reference Citation Analysis]
143 Joshi C, Chaudhari A, Joshi C, Joshi M, Bagatharia S. Repurposing of the herbal formulations: molecular docking and molecular dynamics simulation studies to validate the efficacy of phytocompounds against SARS-CoV-2 proteins. J Biomol Struct Dyn 2021;:1-15. [PMID: 33988079 DOI: 10.1080/07391102.2021.1922095] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
144 Singh B, Mal G, Verma V, Tiwari R, Khan MI, Mohapatra RK, Mitra S, Alyami SA, Emran TB, Dhama K, Moni MA. Stem cell therapies and benefaction of somatic cell nuclear transfer cloning in COVID-19 era. Stem Cell Res Ther 2021;12:283. [PMID: 33980321 DOI: 10.1186/s13287-021-02334-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
145 Abdelmohsen UR, Albohy A, Abdulrazik BS, Bayoumi SAL, Malak LG, Khallaf ISA, Bringmann G, Farag SF. Natural coumarins as potential anti-SARS-CoV-2 agents supported by docking analysis. RSC Adv 2021;11:16970-9. [PMID: 35479715 DOI: 10.1039/d1ra01989a] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
146 Gupta A, Pradhan A, Maurya VK, Kumar S, Theengh A, Puri B, Saxena SK. Therapeutic approaches for SARS-CoV-2 infection. Methods 2021:S1046-2023(21)00126-2. [PMID: 33962011 DOI: 10.1016/j.ymeth.2021.04.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
147 Brazell LR, Stetz S, Hipp A, Taylor S, Stark N, Jensen K, Islam Juel MA, Deegan P, Munir M, Schlueter J, Weller J, Gibas C. Environmental Screening for Surface SARS-CoV-2 Contamination in Urban High-Touch Areas.. [DOI: 10.1101/2021.05.04.21256107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
148 Krishnan S, Subramanian D, Rajamani SSP. A Review on Catastrophic Evolution of SARS-CoV to SARS-CoV2: A Global Pandemic. COVID 2021;2:8-25. [DOI: 10.2174/2666796701999200917125700] [Reference Citation Analysis]
149 Moshfegh F, Khosraviani F, Moghaddasi N, Limoodi SFSJ, Boluki E. Antiviral optical techniques as a possible novel approach to COVID-19 treatment. J Innov Opt Health Sci 2021;14:2130002. [DOI: 10.1142/s1793545821300020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
150 Liang C, Hui N, Liu Y, Qiao G, Li J, Tian L, Ju X, Jia M, Liu H, Cao W, Yu P, Li H, Ren X. Insights into forsythia honeysuckle (Lianhuaqingwen) capsules: A Chinese herbal medicine repurposed for COVID-19 pandemic. Phytomedicine Plus 2021;1:100027. [DOI: 10.1016/j.phyplu.2021.100027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
151 Rao DS, Nomier YA, Ahmed RA, Noureldeen AN. Retrospective and prospective monitoring in post COVID-19 complications and an approach for vigilance in Post-recovery period. J Adv Pharm Technol Res 2021;12:209-14. [PMID: 34159155 DOI: 10.4103/japtr.JAPTR_245_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
152 Orlando V, Coscioni E, Guarino I, Mucherino S, Perrella A, Trama U, Limongelli G, Menditto E. Drug-utilisation profiles and COVID-19. Sci Rep 2021;11:8913. [PMID: 33903671 DOI: 10.1038/s41598-021-88398-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
153 Kanimozhi G, Pradhapsingh B, Singh Pawar C, Khan HA, Alrokayan SH, Prasad NR. SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models. Front Pharmacol 2021;12:638334. [PMID: 33967772 DOI: 10.3389/fphar.2021.638334] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
154 Kosari M, Noureddini M, Khamechi SP, Najafi A, Ghaderi A, Sehat M, Banafshe HR. The effect of propolis plus Hyoscyamus niger L. methanolic extract on clinical symptoms in patients with acute respiratory syndrome suspected to COVID-19: A clinical trial. Phytother Res 2021;35:4000-6. [PMID: 33860587 DOI: 10.1002/ptr.7116] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
155 Bhimala KR, Patra GK, Mopuri R, Mutheneni SR. Prediction of COVID-19 cases using the weather integrated deep learning approach for India. Transbound Emerg Dis 2021. [PMID: 33837675 DOI: 10.1111/tbed.14102] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
156 Saha D, Vasuprada TM. Understanding the Trade-offs in Drug Development: Retrospective on Lessons from the Early Phase of the COVID-19 Pandemic. Journal of Developing Societies 2021;37:329-62. [DOI: 10.1177/0169796x21996833] [Reference Citation Analysis]
157 Khadka D, Dhamala MK, Li F, Aryal PC, Magar PR, Bhatta S, Thakur MS, Basnet A, Cui D, Shi S. The use of medicinal plants to prevent COVID-19 in Nepal. J Ethnobiol Ethnomed 2021;17:26. [PMID: 33832492 DOI: 10.1186/s13002-021-00449-w] [Cited by in Crossref: 28] [Cited by in F6Publishing: 35] [Article Influence: 28.0] [Reference Citation Analysis]
158 Agrawal PK, Agrawal C, Blunden G. Rutin: A Potential Antiviral for Repurposing as a SARS-CoV-2 Main Protease (M pro ) Inhibitor. Natural Product Communications 2021;16:1934578X2199172. [DOI: 10.1177/1934578x21991723] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
159 Alharithi F, Almulihi A, Bourouis S, Alroobaea R, Bouguila N. Discriminative Learning Approach Based on Flexible Mixture Model for Medical Data Categorization and Recognition. Sensors (Basel) 2021;21:2450. [PMID: 33918120 DOI: 10.3390/s21072450] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
160 Bourouis S, Bouguila N. Nonparametric learning approach based on infinite flexible mixture model and its application to medical data analysis. Int J Imaging Syst Tech 2021;31:1989-2002. [DOI: 10.1002/ima.22577] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
161 Marmitt DJ, Goettert MI, Rempel C. Compounds of plants with activity against SARS-CoV-2 targets. Expert Rev Clin Pharmacol 2021;14:623-33. [PMID: 33706626 DOI: 10.1080/17512433.2021.1903317] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
162 Das A, Pandita D, Jain GK, Agarwal P, Grewal AS, Khar RK, Lather V. Role of phytoconstituents in the management of COVID-19. Chem Biol Interact 2021;341:109449. [PMID: 33798507 DOI: 10.1016/j.cbi.2021.109449] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
163 Fongnzossie Fedoung E, Biwole AB, Nyangono Biyegue CF, Ngansop Tounkam M, Akono Ntonga P, Nguiamba VP, Essono DM, Forbi Funwi P, Tonga C, Nguenang GM, Kemeuze V, Sonwa DJ, Tsabang N, Bouelet IS, Tize Z, Boum AT, Momo Solefack MC, Betti JL, Nouga Bissoue A, Lehman LG, Mapongmetsem PM, Nneme Nneme L, Ngono Ngane RA, Ngogang Yonkeu J. A review of Cameroonian medicinal plants with potentials for the management of the COVID-19 pandemic. ADV TRADIT MED (ADTM). [DOI: 10.1007/s13596-021-00567-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
164 Kumar S, Viral R, Deep V, Sharma P, Kumar M, Mahmud M, Stephan T. Forecasting major impacts of COVID-19 pandemic on country-driven sectors: challenges, lessons, and future roadmap. Pers Ubiquitous Comput 2021;:1-24. [PMID: 33815032 DOI: 10.1007/s00779-021-01530-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 11.0] [Reference Citation Analysis]
165 Iyer M, Tiwari S, Renu K, Pasha MY, Pandit S, Singh B, Raj N, Krothapalli S, Kwak HJ, Balasubramanian V, Jang SB, G DK, Uttpal A, Narayanasamy A, Kinoshita M, Subramaniam MD, Nachimuthu SK, Roy A, Valsala Gopalakrishnan A, Ramakrishnan P, Cho SG, Vellingiri B. Environmental survival of SARS-CoV-2 - A solid waste perspective. Environ Res 2021;197:111015. [PMID: 33775678 DOI: 10.1016/j.envres.2021.111015] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 24.0] [Reference Citation Analysis]
166 Omokhua-Uyi AG, Van Staden J. Natural product remedies for COVID-19: A focus on safety. S Afr J Bot 2021;139:386-98. [PMID: 33753960 DOI: 10.1016/j.sajb.2021.03.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
167 Anand AV, Balamuralikrishnan B, Kaviya M, Bharathi K, Parithathvi A, Arun M, Senthilkumar N, Velayuthaprabhu S, Saradhadevi M, Al-Dhabi NA, Arasu MV, Yatoo MI, Tiwari R, Dhama K. Medicinal Plants, Phytochemicals, and Herbs to Combat Viral Pathogens Including SARS-CoV-2. Molecules 2021;26:1775. [PMID: 33809963 DOI: 10.3390/molecules26061775] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 31.0] [Reference Citation Analysis]
168 Arrogante O, López-Torre EM, Carrión-García L, Polo A, Jiménez-Rodríguez D. High-Fidelity Virtual Objective Structured Clinical Examinations with Standardized Patients in Nursing Students: An Innovative Proposal during the COVID-19 Pandemic. Healthcare (Basel) 2021;9:355. [PMID: 33804700 DOI: 10.3390/healthcare9030355] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
169 Namazi H, Selamat A, Krejcar O. COMPLEXITY-BASED ANALYSIS OF THE ALTERATIONS IN THE STRUCTURE OF CORONAVIRUSES. Fractals 2021;29:2150123. [DOI: 10.1142/s0218348x21501231] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
170 Cai Z, Zheng S, Huang Y, Au WW, Qiu Z, Wu K. The Interactive Effects of Cognition on Coping Styles among Chinese during the COVID-19 Pandemic. Int J Environ Res Public Health 2021;18:3148. [PMID: 33803737 DOI: 10.3390/ijerph18063148] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
171 Attia YA, El-Saadony MT, Swelum AA, Qattan SYA, Al-Qurashi AD, Asiry KA, Shafi ME, Elbestawy AR, Gado AR, Khafaga AF, Hussein EOS, Ba-Awadh H, Tiwari R, Dhama K, Alhussaini B, Alyileili SR, El-Tarabily KA, Abd El-Hack ME. COVID-19: pathogenesis, advances in treatment and vaccine development and environmental impact-an updated review. Environ Sci Pollut Res Int 2021;28:22241-64. [PMID: 33733422 DOI: 10.1007/s11356-021-13018-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 15.0] [Reference Citation Analysis]
172 Ertas YN, Mahmoodi M, Shahabipour F, Jahed V, Diltemiz SE, Tutar R, Ashammakhi N. Role of biomaterials in the diagnosis, prevention, treatment, and study of corona virus disease 2019 (COVID-19). Emergent Mater 2021;:1-21. [PMID: 33748672 DOI: 10.1007/s42247-021-00165-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
173 Maraghi E, Saki Malehi A, Rahim F. Global Health Security Capacity Against COVID-19 Outbreak: An Analysis of Annual Data from 210 Countries and Territories. Jundishapur J Health Sci 2021;12. [DOI: 10.5812/jjhs.110814] [Reference Citation Analysis]
174 Teodorescu M. An Overview of a Year with COVID-19: What We Know? ELECTRON J GEN MED 2021;18:em286. [DOI: 10.29333/ejgm/9765] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
175 Kim S, Jung CG, Lee JY, Kim G, Choi SW, Jin HJ, Park HK. Characterization of asthma and risk factors for delayed SARS-CoV-2 clearance in adult COVID-19 inpatients in Daegu. Allergy 2021;76:918-21. [PMID: 33012003 DOI: 10.1111/all.14609] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
176 Kshirsagar SG, Rao RV. Antiviral and Immunomodulation Effects of Artemisia. Medicina (Kaunas) 2021;57:217. [PMID: 33673527 DOI: 10.3390/medicina57030217] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
177 Mishra A, Bentur SA, Thakral S, Garg R, Duggal B. The use of integrative therapy based on Yoga and Ayurveda in the treatment of a high-risk case of COVID-19/SARS-CoV-2 with multiple comorbidities: a case report. J Med Case Rep 2021;15:95. [PMID: 33627186 DOI: 10.1186/s13256-020-02624-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
178 Kunnumakkara AB, Rana V, Parama D, Banik K, Girisa S, Henamayee S, Thakur KK, Dutta U, Garodia P, Gupta SC, Aggarwal BB. COVID-19, cytokines, inflammation, and spices: How are they related? Life Sci 2021;:119201. [PMID: 33607159 DOI: 10.1016/j.lfs.2021.119201] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 24.0] [Reference Citation Analysis]
179 Chandra A, Chaudhary M, Qamar I, Singh N, Nain V. In silico identification and validation of natural antiviral compounds as potential inhibitors of SARS-CoV-2 methyltransferase. J Biomol Struct Dyn 2021;:1-11. [PMID: 33583328 DOI: 10.1080/07391102.2021.1886174] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 11.0] [Reference Citation Analysis]
180 Elsayed AA, Darwish SF, Zewail MB, Mohammed M, Saeed H, Rabea H. Antibiotic misuse and compliance with infection control measures during COVID-19 pandemic in community pharmacies in Egypt. Int J Clin Pract 2021;75:e14081. [PMID: 33559255 DOI: 10.1111/ijcp.14081] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
181 Ali SG, Ansari MA, Alzohairy MA, Almatroudi A, Alomary MN, Alghamdi S, Rehman S, Khan HM. Natural Products and Nutrients against Different Viral Diseases: Prospects in Prevention and Treatment of SARS-CoV-2. Medicina (Kaunas) 2021;57:169. [PMID: 33673004 DOI: 10.3390/medicina57020169] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
182 Iqbal Yatoo M, Hamid Z, Rather I, Nazir QUA, Bhat RA, Ul Haq A, Magray SN, Haq Z, Sah R, Tiwari R, Natesan S, Bilal M, Harapan H, Dhama K. Immunotherapies and immunomodulatory approaches in clinical trials - a mini review. Hum Vaccin Immunother 2021;17:1897-909. [PMID: 33577374 DOI: 10.1080/21645515.2020.1871295] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
183 Yadav AK, Verma D, Kumar A, Kumar P, Solanki PR. The perspectives of biomarker-based electrochemical immunosensors, artificial intelligence and the Internet of Medical Things toward COVID-19 diagnosis and management. Mater Today Chem 2021;20:100443. [PMID: 33615086 DOI: 10.1016/j.mtchem.2021.100443] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 15.0] [Reference Citation Analysis]
184 Hussain Y, Muhammad K, Umer MF, Omarkhail A, Khan S, Kamran M, Rashid H, Khan Z. Coronavirus Disease 2019 in 5 Neighboring Limited-Resource Countries: A Financial and Health Threat. Value Health Reg Issues 2021;24:114-6. [PMID: 33545492 DOI: 10.1016/j.vhri.2020.06.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
185 Bessalah S, Jebahi S, Mejri N, Salhi I, Khorchani T, Hammadi M. Perspective on therapeutic and diagnostic potential of camel nanobodies for coronavirus disease-19 (COVID-19). 3 Biotech 2021;11:89. [PMID: 33500874 DOI: 10.1007/s13205-021-02647-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 19.0] [Reference Citation Analysis]
186 Sharov KS, Koltzov Institute of Developmental Biology of Russian Academy of Sciences. Ideological Struggle with COVID-19 and Disproportional Public Policy Measures in Russia. Beacon J Stud Ideol Ment Dimens 2021;3:020610119. [DOI: 10.55269/thebeacon.3.020610119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
187 Al-Bari MAA, Hossain S, Zahan MKE. Exploration of sex-specific and age-dependent COVID-19 fatality rate in Bangladesh population. World J Radiol 2021; 13(1): 1-18 [PMID: 33574990 DOI: 10.4329/wjr.v13.i1.1] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
188 Chung HY, Jian MJ, Chang CK, Lin JC, Yeh KM, Chen CW, Chiu SK, Wang YH, Liao SJ, Li SY, Hsieh SS, Tsai SH, Perng CL, Yang JR, Liu MT, Chang FY, Shang HS. Novel dual multiplex real-time RT-PCR assays for the rapid detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus using the BD MAX open system. Emerg Microbes Infect 2021;10:161-6. [PMID: 33410371 DOI: 10.1080/22221751.2021.1873073] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 31.0] [Reference Citation Analysis]
189 Chitra SM, Mallika P, Anbu N, NarayanaBabu R, SugunaBai A, David Paul Raj RS, Premnath D. An Open Clinical Evaluation Of Selected Siddha Regimen In Expediting The Management Of Covid-19 -A Randomized Controlled Study. J Ayurveda Integr Med 2021. [PMID: 33519133 DOI: 10.1016/j.jaim.2021.01.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
190 Fakhri S, Piri S, Majnooni MB, Farzaei MH, Echeverría J. Targeting Neurological Manifestations of Coronaviruses by Candidate Phytochemicals: A Mechanistic Approach. Front Pharmacol 2020;11:621099. [PMID: 33708124 DOI: 10.3389/fphar.2020.621099] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
191 C T S, M D, P R R, K M, E M A, Balachandran I. Chemical profiling of selected Ayurveda formulations recommended for COVID-19. Beni Suef Univ J Basic Appl Sci 2021;10:2. [PMID: 33457430 DOI: 10.1186/s43088-020-00089-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
192 Mitra D, Verma D, Mahakur B, Kamboj A, Srivastava R, Gupta S, Pandey A, Arora B, Pant K, Panneerselvam P, Ghosh A, Barik DP, Mohapatra PKD. Molecular docking and simulation studies of natural compounds of Vitex negundo L. against papain-like protease (PLpro) of SARS CoV-2 (coronavirus) to conquer the pandemic situation in the world. J Biomol Struct Dyn 2021;:1-22. [PMID: 33459176 DOI: 10.1080/07391102.2021.1873185] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
193 Sefah IA, Ogunleye OO, Essah DO, Opanga SA, Butt N, Wamaitha A, Guantai AN, Chikowe I, Khuluza F, Kibuule D, Nambahu L, Abubakar AR, Sani IH, Saleem Z, Kalungia AC, Thi Phuong TN, Haque M, Islam S, Kumar S, Sneddon J, Wamboga J, Wale J, Miljković N, Kurdi A, Martin AP, Godman B. Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications. Front Pharmacol 2020;11:588106. [PMID: 33628173 DOI: 10.3389/fphar.2020.588106] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 23.0] [Reference Citation Analysis]
194 Siddique F, Abbas RZ, Mansoor MK, Alghamdi ES, Saeed M, Ayaz MM, Rahman M, Mahmood MS, Iqbal A, Manzoor M, Abbas A, Javaid A, Hussain I. An Insight Into COVID-19: A 21st Century Disaster and Its Relation to Immunocompetence and Food Antioxidants. Front Vet Sci 2020;7:586637. [PMID: 33521076 DOI: 10.3389/fvets.2020.586637] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
195 Iqubal A, Hoda F, Najmi AK, Haque SE. Macrophage Activation and Cytokine Release Syndrome in COVID-19: Current Updates and Analysis of Repurposed and Investigational Anti-Cytokine Drugs. Drug Res (Stuttg) 2021;71:173-9. [PMID: 33434935 DOI: 10.1055/a-1291-7692] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
196 Remali J, Aizat WM. A Review on Plant Bioactive Compounds and Their Modes of Action Against Coronavirus Infection. Front Pharmacol 2020;11:589044. [PMID: 33519449 DOI: 10.3389/fphar.2020.589044] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 23.0] [Reference Citation Analysis]
197 Chiem K, Morales Vasquez D, Park JG, Platt RN, Anderson T, Walter MR, Kobie JJ, Ye C, Martinez-Sobrido L. Generation and Characterization of recombinant SARS-CoV-2 expressing reporter genes. J Virol 2021:JVI. [PMID: 33431557 DOI: 10.1128/JVI.02209-20] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 24.0] [Reference Citation Analysis]
198 Saxena S, Kumar S, Hajare SN, Gupta S, Gautam S, Ghosh SK. 'BhAVI-23'-A spice-herb based dietary infusion possessing in-vitro anti-viral potential. J Ayurveda Integr Med 2021;12:312-9. [PMID: 33413968 DOI: 10.1016/j.jaim.2020.11.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
199 Silva-Sobrinho RA, Zilly A, Silva RMMD, Arcoverde MAM, Deschutter EJ, Palha PF, Bernardi AS. Coping with COVID-19 in an international border region: health and economy. Rev Lat Am Enfermagem 2021;29:e3398. [PMID: 33439950 DOI: 10.1590/1518-8345.4659.3398] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
200 Martí M, Tuñón-Molina A, Aachmann FL, Muramoto Y, Noda T, Takayama K, Serrano-Aroca Á. Protective Face Mask Filter Capable of Inactivating SARS-CoV-2, and Methicillin-Resistant Staphylococcus aureus and Staphylococcus epidermidis. Polymers (Basel) 2021;13:E207. [PMID: 33435608 DOI: 10.3390/polym13020207] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 40.0] [Reference Citation Analysis]
201 Boutebal SE, Madani A, Bryant CR. COVID-19 pandemic: rapid survey on social and mobility impact in Algerian cities. Z Gesundh Wiss 2021;:1-10. [PMID: 33432289 DOI: 10.1007/s10389-020-01457-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
202 Gowrishankar S, Muthumanickam S, Kamaladevi A, Karthika C, Jothi R, Boomi P, Maniazhagu D, Pandian SK. Promising phytochemicals of traditional Indian herbal steam inhalation therapy to combat COVID-19 - An in silico study. Food Chem Toxicol 2021;148:111966. [PMID: 33412235 DOI: 10.1016/j.fct.2020.111966] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 23.0] [Reference Citation Analysis]
203 Haidar MA, Jourdi H, Haj Hassan Z, Ashekyan O, Fardoun M, Wehbe Z, Maaliki D, Wehbe M, Mondello S, Abdelhady S, Shahjouei S, Bizri M, Mechref Y, Gold MS, Dbaibo G, Zaraket H, Eid AH, Kobeissy F. Neurological and Neuropsychological Changes Associated with SARS-CoV-2 Infection: New Observations, New Mechanisms. Neuroscientist 2021;:1073858420984106. [PMID: 33393420 DOI: 10.1177/1073858420984106] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]
204 Paixão W, Cordeiro I, Körössy N. Efeitos da pandemia do COVID-19 sobre o turismo em Fernando de Noronha ao longo do primeiro semestre de 2020. RBTUR 2020;15:2128. [DOI: 10.7784/rbtur.v15i1.2128] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
205 Saini J, Dutta M, Marques G. Indoor Air Quality Monitoring Systems and COVID-19. Studies in Systems, Decision and Control 2021. [DOI: 10.1007/978-3-030-67716-9_9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
206 Chauhan DS, Yadav S, Quraishi M. Natural products as environmentally safe and green approach to combat Covid-19. Current Research in Green and Sustainable Chemistry 2021;4:100114. [DOI: 10.1016/j.crgsc.2021.100114] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
207 Mtewa AG, Bvunzawabaya JT. Molecular optimization of phytochemicals into antidotes. Phytochemistry, the Military and Health 2021. [DOI: 10.1016/b978-0-12-821556-2.00006-2] [Reference Citation Analysis]
208 Zafar S, Perveen S, Iqbal N, Khan MK, Alotaibi MO, Mohammed AE. Medicinal Plants as COVID-19 Remedy. Alternative Medicine Interventions for COVID-19 2021. [DOI: 10.1007/978-3-030-67989-7_2] [Reference Citation Analysis]
209 Moshfegh F, Ezzati A, Ezzati A, Bahraini M, Boluki E, Fazeli A. Therapeutic and Diagnostic Approaches for SARS-CoV-2. VP 2021;07:63-79. [DOI: 10.4236/vp.2021.72006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
210 Sobti P, Nayyar A, Nagrath P. Time Series Forecasting for Coronavirus (COVID-19). Communications in Computer and Information Science 2021. [DOI: 10.1007/978-981-16-1480-4_27] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
211 Lakhal S, Guennoun Z. Covid-19 and the Pulmonary Immune System Fight: A Game Theory Model. Advances in Intelligent Systems and Computing 2021. [DOI: 10.1007/978-3-030-71187-0_47] [Reference Citation Analysis]
212 Polgampala S, M.n.s. E, G.a.d S, A.s. P. Perceptions of participants on Online Learning in the Outbreak of COVID-19: Case Study. SSRN Journal. [DOI: 10.2139/ssrn.3808994] [Reference Citation Analysis]
213 刘 宏. An Effective Analysis of 15 People Suffered from Novel Coronavirus Pneumonia Treated by Integrated Traditional Chinese and Western Medicine. ACM 2021;11:5404-5412. [DOI: 10.12677/acm.2021.1111799] [Reference Citation Analysis]
214 Jassin Z, Heric A, Mujkic A, Baralic E. COVID-19 Diagnostic Approaches: An Overview. IFMBE Proceedings 2021. [DOI: 10.1007/978-3-030-73909-6_100] [Reference Citation Analysis]
215 Bourouis S, Sallay H, Bouguila N. A Competitive Generalized Gamma Mixture Model for Medical Image Diagnosis. IEEE Access 2021;9:13727-36. [DOI: 10.1109/access.2021.3051758] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
216 Singh E, Khan RJ, Jha RK, Amera GM, Jain M, Singh RP, Muthukumaran J, Singh AK. Computational Drug Repurposing for the Development of Drugs Against Coronaviruses. Methods in Pharmacology and Toxicology 2021. [DOI: 10.1007/7653_2020_68] [Reference Citation Analysis]
217 Oke KI, Ogundiran OO, Mbada CE, Ogunkunle E. Knowledge, Awareness and Impact of Coronavirus Disease Lockdown on Training, Fitness and Personal Parameters: A Survey of Nigerian Athletes. Central European Journal of Sport Sciences and Medicine 2021;34:67-75. [DOI: 10.18276/cej.2021.2-06] [Reference Citation Analysis]
218 Vastyanov RS, Kozishkurt OV, Golubyatnikov MI, Kamarali AO. POSSIBLE PATHOGENETIC APPROACHES TO THE TREATMENT OF ACUTE RESPIRATORY DISEASE COVID-19 CAUSED BY CORONAVIRUS SARS-COV-2. VPBM 2021;2:14. [DOI: 10.29254/2077-4214-2021-2-160-14-18] [Reference Citation Analysis]
219 Satoto BD, Utoyo MI, Rulaningtyas R. Prediction of pneumonia COVID19 using a custom convolutional neural network with data augmentation. INTERNATIONAL CONFERENCE ON MATHEMATICS, COMPUTATIONAL SCIENCES AND STATISTICS 2020 2021. [DOI: 10.1063/5.0045329] [Reference Citation Analysis]
220 Tripathi P, Singh A. Biofertilizers: “An ace in the hole” in medicinal and aromatic plants cultivation. Biofertilizers 2021. [DOI: 10.1016/b978-0-12-821667-5.00010-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
221 Sharov KS. Strategies of Consistent Planning Healthcare Management During the SARS-CoV-2 Pandemic: Russian and European Experience. SARS-CoV-2 and Coronacrisis 2021. [DOI: 10.1007/978-981-16-2605-0_17] [Reference Citation Analysis]
222 Singh E, Khan RJ, Jha RK, Amera GM, Jain M, Singh RP, Muthukumaran J, Singh AK. Ligand-Based Approaches for the Development of Drugs Against SARS-CoV-2. Methods in Pharmacology and Toxicology 2021. [DOI: 10.1007/7653_2020_65] [Reference Citation Analysis]
223 Bidzan M, Bidzan-Bluma I, Szulman-Wardal A, Stueck M, Bidzan M. Does Self-Efficacy and Emotional Control Protect Hospital Staff From COVID-19 Anxiety and PTSD Symptoms? Psychological Functioning of Hospital Staff After the Announcement of COVID-19 Coronavirus Pandemic. Front Psychol 2020;11:552583. [PMID: 33424673 DOI: 10.3389/fpsyg.2020.552583] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
224 Simula ER, Manca MA, Jasemi S, Uzzau S, Rubino S, Manchia P, Bitti A, Palermo M, Sechi LA. HCoV-NL63 and SARS-CoV-2 Share Recognized Epitopes by the Humoral Response in Sera of People Collected Pre- and during CoV-2 Pandemic. Microorganisms 2020;8:E1993. [PMID: 33327507 DOI: 10.3390/microorganisms8121993] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
225 Andrade BS, Rangel FS, Santos NO, Freitas ADS, Soares WRA, Siqueira S, Barh D, Góes-Neto A, Birbrair A, Azevedo VAC. Repurposing Approved Drugs for Guiding COVID-19 Prophylaxis: A Systematic Review. Front Pharmacol 2020;11:590598. [PMID: 33390967 DOI: 10.3389/fphar.2020.590598] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
226 Mulaw Belete T. An Up-to-Date Overview of Therapeutic Agents for the Treatment of COVID-19 Disease. Clin Pharmacol 2020;12:203-12. [PMID: 33363416 DOI: 10.2147/CPAA.S284809] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
227 Ahmed I, Hasan M, Akter R, Sarkar BK, Rahman M, Sarker MS, Samad MA. Behavioral preventive measures and the use of medicines and herbal products among the public in response to Covid-19 in Bangladesh: A cross-sectional study. PLoS One 2020;15:e0243706. [PMID: 33306725 DOI: 10.1371/journal.pone.0243706] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
228 Hussain I, Hussain A, Alajmi MF, Rehman MT, Amir S. Impact of repurposed drugs on the symptomatic COVID-19 patients. J Infect Public Health 2021;14:24-38. [PMID: 33341481 DOI: 10.1016/j.jiph.2020.11.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
229 Yabalak E, Ibrahim F, Eliuz EAE, Everest A, Gizir AM. Evaluation of chemical composition, trace element content, antioxidant and antimicrobial activities of Verbascum pseudoholotrichum. Plant Biosystems - An International Journal Dealing with all Aspects of Plant Biology. [DOI: 10.1080/11263504.2020.1852332] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
230 Dhama K, Patel SK, Natesan S, Vora KS, Iqbal Yatoo M, Tiwari R, Saxena SK, Singh KP, Singh R, Malik YS. COVID-19 in the elderly people and advances in vaccination approaches. Hum Vaccin Immunother 2020;16:2938-43. [PMID: 33270497 DOI: 10.1080/21645515.2020.1842683] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 9.5] [Reference Citation Analysis]
231 Richard SA, Kampo S, Esquijarosa Hechavarria M. Elucidating the pivotal role of convalescent plasma therapy in critically ill COVID-19 patients: A review. Hematol Rep 2020;12:8630. [PMID: 33324480 DOI: 10.4081/hr.2020.8630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
232 Pasrija R, Naime M. The deregulated immune reaction and cytokines release storm (CRS) in COVID-19 disease.Int Immunopharmacol. 2021;90:107225. [PMID: 33302033 DOI: 10.1016/j.intimp.2020.107225] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 21.5] [Reference Citation Analysis]
233 Martí M, Tuñón-molina A, Aachmann FL, Muramoto Y, Noda T, Takayama K, Serrano-aroca Á. Protective face mask filter capable of inactivating SARS-CoV-2, and methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.. [DOI: 10.1101/2020.11.24.396028] [Reference Citation Analysis]
234 Shaikh SS, Jose AP, Nerkar DA, Vijaykumar Kv M, Shaikh SK. COVID-19 pandemic crisis-a complete outline of SARS-CoV-2. Futur J Pharm Sci 2020;6:116. [PMID: 33224993 DOI: 10.1186/s43094-020-00133-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
235 Ng JY. Global research trends at the intersection of coronavirus disease 2019 (COVID-19) and traditional, integrative, and complementary and alternative medicine: a bibliometric analysis. BMC Complement Med Ther 2020;20:353. [PMID: 33225948 DOI: 10.1186/s12906-020-03151-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
236 Dias A, Scavarda A, Reis A, Silveira H, Ebecken N. Managerial Strategies for Long-Term Care Organization Professionals: COVID-19 Pandemic Impacts. Sustainability 2020;12:9682. [DOI: 10.3390/su12229682] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
237 Brizek MG, Frash RE, McLeod BM, Patience MO. Independent restaurant operator perspectives in the wake of the COVID-19 pandemic. Int J Hosp Manag 2021;93:102766. [PMID: 33230361 DOI: 10.1016/j.ijhm.2020.102766] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 15.0] [Reference Citation Analysis]
238 Banerjee D, Kosagisharaf JR, Sathyanarayana Rao TS. 'The dual pandemic' of suicide and COVID-19: A biopsychosocial narrative of risks and prevention. Psychiatry Res 2021;295:113577. [PMID: 33229123 DOI: 10.1016/j.psychres.2020.113577] [Cited by in Crossref: 71] [Cited by in F6Publishing: 75] [Article Influence: 35.5] [Reference Citation Analysis]
239 Kotta S, Aldawsari HM, Badr-Eldin SM, Alhakamy NA, Md S, Nair AB, Deb PK. Combating the Pandemic COVID-19: Clinical Trials, Therapies and Perspectives. Front Mol Biosci 2020;7:606393. [PMID: 33282914 DOI: 10.3389/fmolb.2020.606393] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
240 Matveeva T, Khafizova G, Sokornova S. In Search of Herbal Anti-SARS-Cov2 Compounds. Front Plant Sci 2020;11:589998. [PMID: 33304368 DOI: 10.3389/fpls.2020.589998] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
241 Sun X, Jiang J, Wang Y, Liu S. Exploring the potential therapeutic effect of traditional Chinese medicine on coronavirus disease 2019 (COVID-19) through a combination of data mining and network pharmacology analysis. Eur J Integr Med 2020;40:101242. [PMID: 33163124 DOI: 10.1016/j.eujim.2020.101242] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
242 Banerjee S, Kar A, Mukherjee PK, Haldar PK, Sharma N, Katiyar CK. Immunoprotective potential of Ayurvedic herb Kalmegh (Andrographis paniculata) against respiratory viral infections - LC-MS/MS and network pharmacology analysis. Phytochem Anal 2021;32:629-39. [PMID: 33167083 DOI: 10.1002/pca.3011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
243 Mondal P, Natesh J, Abdul Salam AA, Thiyagarajan S, Meeran SM. Traditional medicinal plants against replication, maturation and transmission targets of SARS-CoV-2: computational investigation. J Biomol Struct Dyn 2020;:1-18. [PMID: 33150860 DOI: 10.1080/07391102.2020.1842246] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
244 Singh E, Khan RJ, Jha RK, Amera GM, Jain M, Singh RP, Muthukumaran J, Singh AK. A comprehensive review on promising anti-viral therapeutic candidates identified against main protease from SARS-CoV-2 through various computational methods. J Genet Eng Biotechnol 2020;18:69. [PMID: 33141358 DOI: 10.1186/s43141-020-00085-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 14.5] [Reference Citation Analysis]
245 J J B, A R M, S A R M, S M J M. A New Look at the LDRT treatment for COVID-19 Associated Pneumonia: The Issues of Antiviral Resistance and Virus Spread-Ability. J Biomed Phys Eng 2020;10:549-52. [PMID: 33134212 DOI: 10.31661/jbpe.v0i0.2007-1151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
246 Rocha Martinez TLD, da Silva AM. Reviewing stress in COVID-19 times. IJFCM 2020;4:150-151. [DOI: 10.15406/ijfcm.2020.04.00205] [Reference Citation Analysis]
247 Palit P, Chattopadhyay D, Thomas S, Kundu A, Kim HS, Rezaei N. Phytopharmaceuticals mediated Furin and TMPRSS2 receptor blocking: can it be a potential therapeutic option for Covid-19? Phytomedicine 2021;85:153396. [PMID: 33380375 DOI: 10.1016/j.phymed.2020.153396] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
248 Wang Y, Wang P, Wang H, Luo Y, Wan L, Jiang M, Chu Y. Lactoferrin for the treatment of COVID-19 (Review). Exp Ther Med 2020;20:272. [PMID: 33199997 DOI: 10.3892/etm.2020.9402] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 12.5] [Reference Citation Analysis]
249 Saqib M. Forecasting COVID-19 outbreak progression using hybrid polynomial-Bayesian ridge regression model. Appl Intell 2021;51:2703-13. [DOI: 10.1007/s10489-020-01942-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
250 Hasan MA, Carmel Mary Esther A, Dey A, Mukhopadhyay AK. A review on coronavirus survivability on material’s surfaces: present research scenarios, technologies and future directions. Surface Engineering 2020;36:1226-39. [DOI: 10.1080/02670844.2020.1833277] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
251 Agrawal M, Saraf S, Saraf S, Murty US, Kurundkar SB, Roy D, Joshi P, Sable D, Choudhary YK, Kesharwani P, Alexander A. In-line treatments and clinical initiatives to fight against COVID-19 outbreak. Respir Med 2020;:106192. [PMID: 33199136 DOI: 10.1016/j.rmed.2020.106192] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
252 Chellasamy G, Arumugasamy SK, Govindaraju S, Yun K. Analytical insights of COVID-19 pandemic. Trends Analyt Chem 2020;133:116072. [PMID: 33100439 DOI: 10.1016/j.trac.2020.116072] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
253 Babich O, Sukhikh S, Prosekov A, Asyakina L, Ivanova S. Medicinal Plants to Strengthen Immunity during a Pandemic. Pharmaceuticals (Basel) 2020;13:E313. [PMID: 33076514 DOI: 10.3390/ph13100313] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 13.5] [Reference Citation Analysis]
254 Janda L, Mihalčin M, Šťastná M. Is a healthy microbiome responsible for lower mortality in COVID-19? Biologia (Bratisl) 2020;:1-11. [PMID: 33078028 DOI: 10.2478/s11756-020-00614-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
255 Zhang B, Yue D, Wang Y, Wang F, Wu S, Hou H. The dynamics of immune response in COVID-19 patients with different illness severity. J Med Virol 2021;93:1070-7. [PMID: 32910461 DOI: 10.1002/jmv.26504] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
256 Sukardiman, Ervina M, Fadhil Pratama MR, Poerwono H, Siswodihardjo S. The coronavirus disease 2019 main protease inhibitor from Andrographis paniculata (Burm. f) Ness. J Adv Pharm Technol Res 2020;11:157-62. [PMID: 33425697 DOI: 10.4103/japtr.JAPTR_84_20] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
257 Chinsembu KC. Coronaviruses and Nature's Pharmacy for the Relief of Coronavirus Disease 2019. Rev Bras Farmacogn 2020;:1-19. [PMID: 33041391 DOI: 10.1007/s43450-020-00104-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
258 Zyoud SH, Zyoud AH. Coronavirus disease-19 in environmental fields: a bibliometric and visualization mapping analysis. Environ Dev Sustain. 2020;1-29. [PMID: 33041643 DOI: 10.1007/s10668-020-01004-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 10.5] [Reference Citation Analysis]
259 Farah Fazwa MA, Norhayati S, Syafiqah Nabilah SB, Keeren SR. Effects of Different Combination of Growing Media on Growth and Total Phenolic Content in Labisia pumila (Kacip Fatimah). J Nat Prod Resour 2020;6:258-261. [DOI: 10.30799/jnpr.091.20060201] [Reference Citation Analysis]
260 Khanna K, Kohli SK, Kaur R, Bhardwaj A, Bhardwaj V, Ohri P, Sharma A, Ahmad A, Bhardwaj R, Ahmad P. Herbal immune-boosters: Substantial warriors of pandemic Covid-19 battle. Phytomedicine 2021;85:153361. [PMID: 33485605 DOI: 10.1016/j.phymed.2020.153361] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 24.5] [Reference Citation Analysis]
261 Kouznetsov VV. COVID-19 treatment: Much research and testing, but far, few magic bullets against SARS-CoV-2 coronavirus. Eur J Med Chem 2020;203:112647. [PMID: 32693298 DOI: 10.1016/j.ejmech.2020.112647] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
262 Kashyap VK, Dhasmana A, Yallapu MM, Chauhan SC, Jaggi M. Withania somnifera as a potential future drug molecule for COVID-19. Future Drug Discov 2020;2:FDD50. [PMID: 33269342 DOI: 10.4155/fdd-2020-0024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
263 Sah R, Pokhrel N, Fathah Z, Ozaki A, Bhandari D, Kotera Y, Shah NP, Sigdel S, Vora KS, Natesan SK, Patel SK, Tiwari R, Malik YS, Yatoo MI, Rodriguez-morales AJ, Dhama K. SARS-CoV-2 / COVID-19: Salient Facts and Strategies to Combat Ongoing Pandemic. J Pure Appl Microbiol 2020;14:1663-1674. [DOI: 10.22207/jpam.14.3.04] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
264 Chakraborty S, Choudhary AK, Sarma M, Hazarika MK. Reaction order and neural network approaches for the simulation of COVID-19 spreading kinetic in India. Infect Dis Model 2020;5:737-47. [PMID: 32989426 DOI: 10.1016/j.idm.2020.09.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
265 Renu K, Subramaniam MD, Chakraborty R, Myakala H, Iyer M, Bharathi G, Siva K, Vellingiri B, Valsala Gopalakrishnan A. The role of Interleukin-4 in COVID-19 associated male infertility - A hypothesis. J Reprod Immunol 2020;142:103213. [PMID: 33080435 DOI: 10.1016/j.jri.2020.103213] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
266 Ye C, Chiem K, Park JG, Oladunni F, Platt RN 2nd, Anderson T, Almazan F, de la Torre JC, Martinez-Sobrido L. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome. mBio 2020;11:e02168-20. [PMID: 32978313 DOI: 10.1128/mBio.02168-20] [Cited by in Crossref: 44] [Cited by in F6Publishing: 50] [Article Influence: 22.0] [Reference Citation Analysis]
267 Martínez-López JÁ, Lázaro-Pérez C, Gómez-Galán J, Fernández-Martínez MDM. Psychological Impact of COVID-19 Emergency on Health Professionals: Burnout Incidence at the Most Critical Period in Spain. J Clin Med 2020;9:E3029. [PMID: 32962258 DOI: 10.3390/jcm9093029] [Cited by in Crossref: 56] [Cited by in F6Publishing: 61] [Article Influence: 28.0] [Reference Citation Analysis]
268 Saini P. COVID-19 pandemic: potential phase III vaccines in development. TABCJ. [DOI: 10.52679/tabcj.2020.0004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
269 Ogunleye OO, Basu D, Mueller D, Sneddon J, Seaton RA, Yinka-Ogunleye AF, Wamboga J, Miljković N, Mwita JC, Rwegerera GM, Massele A, Patrick O, Niba LL, Nsaikila M, Rashed WM, Hussein MA, Hegazy R, Amu AA, Boahen-Boaten BB, Matsebula Z, Gwebu P, Chirigo B, Mkhabela N, Dlamini T, Sithole S, Malaza S, Dlamini S, Afriyie D, Asare GA, Amponsah SK, Sefah I, Oluka M, Guantai AN, Opanga SA, Sarele TV, Mafisa RK, Chikowe I, Khuluza F, Kibuule D, Kalemeera F, Mubita M, Fadare J, Sibomana L, Ramokgopa GM, Whyte C, Maimela T, Hugo J, Meyer JC, Schellack N, Rampamba EM, Visser A, Alfadl A, Malik EM, Malande OO, Kalungia AC, Mwila C, Zaranyika T, Chaibva BV, Olaru ID, Masuka N, Wale J, Hwenda L, Kamoga R, Hill R, Barbui C, Bochenek T, Kurdi A, Campbell S, Martin AP, Phuong TNT, Thanh BN, Godman B. Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future. Front Pharmacol 2020;11:1205. [PMID: 33071775 DOI: 10.3389/fphar.2020.01205] [Cited by in Crossref: 71] [Cited by in F6Publishing: 81] [Article Influence: 35.5] [Reference Citation Analysis]
270 de Almeida SMV, Santos Soares JC, Dos Santos KL, Alves JEF, Ribeiro AG, Jacob ÍTT, da Silva Ferreira CJ, Dos Santos JC, de Oliveira JF, de Carvalho Junior LB, de Lima MDCA. COVID-19 therapy: What weapons do we bring into battle? Bioorg Med Chem 2020;28:115757. [PMID: 32992245 DOI: 10.1016/j.bmc.2020.115757] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
271 Ji P, Chen J, Golding A, Nikolov NP, Saluja B, Ren YR, Sahajwalla CG. Immunomodulatory Therapeutic Proteins in COVID-19: Current Clinical Development and Clinical Pharmacology Considerations. J Clin Pharmacol 2020;60:1275-93. [PMID: 32779201 DOI: 10.1002/jcph.1729] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
272 Campos EVR, Pereira AES, de Oliveira JL, Carvalho LB, Guilger-Casagrande M, de Lima R, Fraceto LF. How can nanotechnology help to combat COVID-19? Opportunities and urgent need. J Nanobiotechnology 2020;18:125. [PMID: 32891146 DOI: 10.1186/s12951-020-00685-4] [Cited by in Crossref: 112] [Cited by in F6Publishing: 116] [Article Influence: 56.0] [Reference Citation Analysis]
273 Tabish TA, Hamblin MR. Multivalent nanomedicines to treat COVID-19: A slow train coming. Nano Today 2020;35:100962. [PMID: 32922510 DOI: 10.1016/j.nantod.2020.100962] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 13.0] [Reference Citation Analysis]
274 Jayaramayya K, Mahalaxmi I, Subramaniam MD, Raj N, Dayem AA, Lim KM, Kim SJ, An JY, Lee Y, Choi Y, Raj A, Cho SG, Vellingiri B. Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment. BMB Rep 2020;53:400-12. [PMID: 32731913 [PMID: 32731913 DOI: 10.5483/bmbrep.2020.53.8.121] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 17.5] [Reference Citation Analysis]
275 Saha I, Ghosh N, Maity D, Sharma N, Mitra K. Inferring the genetic variability in Indian SARS-CoV-2 genomes using consensus of multiple sequence alignment techniques. Infect Genet Evol 2020;85:104522. [PMID: 32889094 DOI: 10.1016/j.meegid.2020.104522] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
276 Alnefaie A, Albogami S. Current approaches used in treating COVID-19 from a molecular mechanisms and immune response perspective. Saudi Pharm J 2020;28:1333-52. [PMID: 32905015 DOI: 10.1016/j.jsps.2020.08.024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
277 Sinclair G, Johnstone P, Hatiboglu MA. Considerations for future novel human-infecting coronavirus outbreaks. Surgical Neurology International 2020;11:260. [DOI: 10.25259/sni_191_2020] [Reference Citation Analysis]
278 Akaji K, Konno H. Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease. Molecules 2020;25:E3920. [PMID: 32867349 DOI: 10.3390/molecules25173920] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
279 Bhavana V, Thakor P, Singh SB, Mehra NK. COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic. Life Sci 2020;261:118336. [PMID: 32846164 DOI: 10.1016/j.lfs.2020.118336] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 18.0] [Reference Citation Analysis]
280 Vivek-Ananth RP, Rana A, Rajan N, Biswal HS, Samal A. In Silico Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-2 Infection. Molecules 2020;25:E3822. [PMID: 32842606 DOI: 10.3390/molecules25173822] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 18.5] [Reference Citation Analysis]
281 Jiménez-Rodríguez D, Arrogante O. Simulated Video Consultations as a Learning Tool in Undergraduate Nursing: Students' Perceptions. Healthcare (Basel) 2020;8:E280. [PMID: 32825269 DOI: 10.3390/healthcare8030280] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
282 Altayb HN, Altayeb NME, Hamadalnil Y, Elsayid M, Mahmoud NE. The current situation of COVID-19 in Sudan. New Microbes New Infect 2020;37:100746. [PMID: 32837731 DOI: 10.1016/j.nmni.2020.100746] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
283 Ahmed I, Hasan M, Akter R, Sarkar BK, Rahman M, Sarker MS, Samad MA. Behavioral preventive measures and the use of medicines and herbal products among the public in response to Covid-19 in Bangladesh: A cross-sectional study.. [DOI: 10.1101/2020.08.15.20175513] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
284 Jiang L, Ma H. Surgical Protocol in a West China Day Surgery Center During the COVID-19 Pandemic: Practice and Experience. Surg Innov 2021;28:53-7. [PMID: 32795165 DOI: 10.1177/1553350620950590] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
285 Laskar P, Yallapu MM, Chauhan SC. "Tomorrow Never Dies": Recent Advances in Diagnosis, Treatment, and Prevention Modalities against Coronavirus (COVID-19) amid Controversies. Diseases 2020;8:E30. [PMID: 32781617 DOI: 10.3390/diseases8030030] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
286 Danta CC. CNS Penetration Ability: A Critical Factor for Drugs in the Treatment of SARS-CoV-2 Brain Infection. ACS Chem Neurosci 2020;11:2137-44. [PMID: 32639711 DOI: 10.1021/acschemneuro.0c00335] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
287 Shankar A, Dubey A, Saini D, Prasad CP. Role of Complementary and Alternative Medicine in Prevention and Treatment of COVID-19: An Overhyped Hope. Chin J Integr Med 2020;26:565-7. [PMID: 32761336 DOI: 10.1007/s11655-020-2851-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 7.5] [Reference Citation Analysis]
288 Fakhar Z, Faramarzi B, Pacifico S, Faramarzi S. Anthocyanin derivatives as potent inhibitors of SARS-CoV-2 main protease: An in-silico perspective of therapeutic targets against COVID-19 pandemic. Journal of Biomolecular Structure and Dynamics 2021;39:6171-83. [DOI: 10.1080/07391102.2020.1801510] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
289 H A, I S, J J B, A J, A R, H Z, S A R M, S M J M. Low Dose Radiation Therapy and Convalescent Plasma: How a Hybrid Method May Maximize Benefits for COVID-19 Patients. J Biomed Phys Eng 2020;10:387-94. [PMID: 32802787 DOI: 10.31661/jbpe.v0i0.2006-1125] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
290 Di Matteo G, Spano M, Grosso M, Salvo A, Ingallina C, Russo M, Ritieni A, Mannina L. Food and COVID-19: Preventive/Co-therapeutic Strategies Explored by Current Clinical Trials and in Silico Studies. Foods 2020;9:E1036. [PMID: 32752217 DOI: 10.3390/foods9081036] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
291 Kaniusas E, Szeles JC, Kampusch S, Alfageme-Lopez N, Yucuma-Conde D, Li X, Mayol J, Neumayer C, Papa M, Panetsos F. Non-invasive Auricular Vagus Nerve Stimulation as a Potential Treatment for Covid19-Originated Acute Respiratory Distress Syndrome. Front Physiol 2020;11:890. [PMID: 32848845 DOI: 10.3389/fphys.2020.00890] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
292 Sood S, Aggarwal V, Aggarwal D, Upadhyay SK, Sak K, Tuli HS, Kumar M, Kumar J, Talwar S. COVID-19 Pandemic: from Molecular Biology, Pathogenesis, Detection, and Treatment to Global Societal Impact. Curr Pharmacol Rep 2020;:1-16. [PMID: 32837855 DOI: 10.1007/s40495-020-00229-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
293 Sharma N, Muthamilarasan M, Prasad A, Prasad M. Genomics approaches to synthesize plant-based biomolecules for therapeutic applications to combat SARS-CoV-2. Genomics 2020;112:4322-31. [PMID: 32717321 DOI: 10.1016/j.ygeno.2020.07.033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
294 Verma HK, Merchant N, Verma MK, Kuru Cİ, Singh AN, Ulucan F, Verma P, Bhattacharya A, Bhaskar LVKS. Current updates on the European and WHO registered clinical trials of coronavirus disease 2019 (COVID-19). Biomed J 2020;43:424-33. [PMID: 32792167 DOI: 10.1016/j.bj.2020.07.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
295 Hou H, Chen J, Wang Y, Lu Y, Zhu Y, Zhang B, Wang F, Mao L, Tang YW, Hu B, Ren Y, Sun Z. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Assay for the Detection of SARS-CoV-2 in Oropharyngeal Swab Specimens. J Clin Microbiol 2020;58:e01288-20. [PMID: 32503847 DOI: 10.1128/JCM.01288-20] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
296 Ye C, Chiem K, Park JG, Oladunni F, Platt RN, Anderson T, Almazan F, de la Torre JC, Martinez-Sobrido L. Rescue of SARS-CoV-2 from a single bacterial artificial chromosome. bioRxiv 2020:2020. [PMID: 32743573 DOI: 10.1101/2020.07.22.216358] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
297 Gasmi A, Tippairote T, Mujawdiya PK, Peana M, Menzel A, Dadar M, Gasmi Benahmed A, Bjørklund G. Micronutrients as immunomodulatory tools for COVID-19 management. Clin Immunol 2020;220:108545. [PMID: 32710937 DOI: 10.1016/j.clim.2020.108545] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 27.0] [Reference Citation Analysis]
298 Mahalaxmi I, Kaavya J, Mohana Devi S, Balachandar V. COVID-19 and olfactory dysfunction: A possible associative approach towards neurodegenerative diseases. J Cell Physiol 2021;236:763-70. [PMID: 32697344 DOI: 10.1002/jcp.29937] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 17.5] [Reference Citation Analysis]
299 Bhattacharya S, Kosey S. Quarantine and Isolation are the two Integral Pillars to Dodge COVID-19 Outbreak. TODENTJ 2020;14:345-347. [DOI: 10.2174/1874210602014010345] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
300 Jafarzadeh A, Chauhan P, Saha B, Jafarzadeh S, Nemati M. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions. Life Sci 2020;257:118102. [PMID: 32687918 DOI: 10.1016/j.lfs.2020.118102] [Cited by in Crossref: 164] [Cited by in F6Publishing: 169] [Article Influence: 82.0] [Reference Citation Analysis]
301 Kouznetsov VV. COVID-19 treatment: Much research and testing, but far, few magic bullets against SARS-CoV-2 coronavirus. Eur J Med Chem 2020;203:112647. [PMID: 32693298 DOI: 10.1016/j.ejmech.2020.112647] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 10.5] [Reference Citation Analysis]
302 Li X, Wang Y, Agostinis P, Rabson A, Melino G, Carafoli E, Shi Y, Sun E. Is hydroxychloroquine beneficial for COVID-19 patients? Cell Death Dis 2020;11:512. [PMID: 32641681 DOI: 10.1038/s41419-020-2721-8] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 29.0] [Reference Citation Analysis]
303 Jaiswal R, Agarwal A, Negi R. Smart solution for reducing the COVID‐19 risk using smart city technology. IET Smart Cities 2020;2:82-8. [DOI: 10.1049/iet-smc.2020.0043] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 20.0] [Reference Citation Analysis]
304 Chennakesavulu K, Reddy GR. The effect of latitude and PM2.5 on spreading of SARS-CoV-2 in tropical and temperate zone countries. Environ Pollut 2020;266:115176. [PMID: 32683090 DOI: 10.1016/j.envpol.2020.115176] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
305 Belete TM. A review on Promising vaccine development progress for COVID-19 disease. Vacunas (English Edition) 2020;21:121-8. [DOI: 10.1016/j.vacune.2020.10.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
306 Diaconu D, Mangalagiu V, Amariucai-Mantu D, Antoci V, Giuroiu CL, Mangalagiu II. Hybrid Quinoline-Sulfonamide Complexes (M2+) Derivatives with Antimicrobial Activity. Molecules 2020;25:E2946. [PMID: 32604828 DOI: 10.3390/molecules25122946] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
307 Boukhatem MN, Setzer WN. Aromatic Herbs, Medicinal Plant-Derived Essential Oils, and Phytochemical Extracts as Potential Therapies for Coronaviruses: Future Perspectives. Plants (Basel) 2020;9:E800. [PMID: 32604842 DOI: 10.3390/plants9060800] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 27.0] [Reference Citation Analysis]
308 Bajaj P, Arya PC. Evolution and spread of SARS-CoV-2 likely to be affected by climate.. [DOI: 10.1101/2020.06.18.147074] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
309 Prasad A, Muthamilarasan M, Prasad M. Synergistic antiviral effects against SARS-CoV-2 by plant-based molecules. Plant Cell Rep 2020;39:1109-14. [PMID: 32561979 DOI: 10.1007/s00299-020-02560-w] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 17.5] [Reference Citation Analysis]
310 Cortés-garcía CJ, Chacón-garcía L, Mejía-benavides JE, Díaz-cervantes E. Tackling the SARS-CoV-2 main protease using hybrid derivatives of 1,5-disubstituted tetrazole-1,2,3-triazoles: an in silico assay. PeerJ Physical Chemistry 2020;2:e10. [DOI: 10.7717/peerj-pchem.10] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
311 Mirzaie A, Halaji M, Dehkordi FS, Ranjbar R, Noorbazargan H. A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19). Complement Ther Clin Pract 2020;40:101214. [PMID: 32891290 DOI: 10.1016/j.ctcp.2020.101214] [Cited by in Crossref: 60] [Cited by in F6Publishing: 69] [Article Influence: 30.0] [Reference Citation Analysis]
312 Narkhede RR, Pise AV, Cheke RS, Shinde SD. Recognition of Natural Products as Potential Inhibitors of COVID-19 Main Protease (Mpro): In-Silico Evidences. Nat Prod Bioprospect 2020;10:297-306. [PMID: 32557405 DOI: 10.1007/s13659-020-00253-1] [Cited by in Crossref: 94] [Cited by in F6Publishing: 76] [Article Influence: 47.0] [Reference Citation Analysis]
313 El Rhazi K, Adarmouch L. Ethical issues related to the hydroxychloroquine treatment prescription for Covid-19. Ethics Med Public Health 2020;14:100547. [PMID: 32835062 DOI: 10.1016/j.jemep.2020.100547] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
314 Belete TM. A review on Promising vaccine development progress for COVID-19 disease. Vacunas 2020;21:121-8. [PMID: 32837460 DOI: 10.1016/j.vacun.2020.05.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 13.5] [Reference Citation Analysis]
315 Sharov KS. Adaptation to SARS-CoV-2 under stress: Role of distorted information. Eur J Clin Invest 2020;50:e13294. [PMID: 32474908 DOI: 10.1111/eci.13294] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
316 Smith ML, Gandolfi S, Coshall PM, Rahman PKSM. Biosurfactants: A Covid-19 Perspective. Front Microbiol 2020;11:1341. [PMID: 32582137 DOI: 10.3389/fmicb.2020.01341] [Cited by in Crossref: 35] [Cited by in F6Publishing: 41] [Article Influence: 17.5] [Reference Citation Analysis]
317 El Taguri A, Nasef A. The world is waiting, use sequential analysis and get us the evidence-based treatment we need for COVID-19. Libyan J Med 2020;15:1770518. [PMID: 32459574 DOI: 10.1080/19932820.2020.1770518] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
318 Kumar V, Singh SB, Singh S. COVID-19: Environment concern and impact of Indian medicinal system. J Environ Chem Eng 2020;8:104144. [PMID: 33520648 DOI: 10.1016/j.jece.2020.104144] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 12.5] [Reference Citation Analysis]
319 Pandey A, Nikam AN, Shreya AB, Mutalik SP, Gopalan D, Kulkarni S, Padya BS, Fernandes G, Mutalik S, Prassl R. Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements. Life Sci 2020;256:117883. [PMID: 32497632 DOI: 10.1016/j.lfs.2020.117883] [Cited by in Crossref: 67] [Cited by in F6Publishing: 72] [Article Influence: 33.5] [Reference Citation Analysis]
320 Sharma P, Tripathi S, Patel SK, Dhama K, Chandra R. SARS-CoV-2 / COVID-19 and its Transmission, Prevention, Treatment and Control - An Update. J Pure Appl Microbiol 2020;14:945-56. [DOI: 10.22207/jpam.14.spl1.32] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
321 Huang J, He Y, Su Q, Yang J. Characteristics of COVID-19 Clinical Trials in China Based on the Registration Data on ChiCTR and ClinicalTrials.gov. Drug Des Devel Ther 2020;14:2159-64. [PMID: 32581514 DOI: 10.2147/DDDT.S254354] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
322 Nair V, Thekkedath R, Sankaran PG. The delayed effect of temperature on the risk of hospitalization due to COVID-19: evidence from Mumbai, India. Epidemiologic Methods 2020;9. [DOI: 10.1515/em-2020-0039] [Reference Citation Analysis]
323 Venugopal A, Ganesan H, Sudalaimuthu Raja SS, Govindasamy V, Arunachalam M, Narayanasamy A, Sivaprakash P, Rahman PKSM, Gopalakrishnan AV, Siama Z, Vellingiri B. Novel wastewater surveillance strategy for early detection of coronavirus disease 2019 hotspots. Curr Opin Environ Sci Health 2020;17:8-13. [PMID: 32501429 DOI: 10.1016/j.coesh.2020.05.003] [Cited by in Crossref: 66] [Cited by in F6Publishing: 75] [Article Influence: 33.0] [Reference Citation Analysis]
324 Renu K, Prasanna PL, Valsala Gopalakrishnan A. Coronaviruses pathogenesis, comorbidities and multi-organ damage - A review. Life Sci 2020;255:117839. [PMID: 32450165 DOI: 10.1016/j.lfs.2020.117839] [Cited by in Crossref: 122] [Cited by in F6Publishing: 135] [Article Influence: 61.0] [Reference Citation Analysis]
325 Madani A, Boutebal SE, Bryant CR. The Psychological Impact of Confinement Linked to the Coronavirus Epidemic COVID-19 in Algeria. Int J Environ Res Public Health 2020;17:E3604. [PMID: 32455550 DOI: 10.3390/ijerph17103604] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 14.5] [Reference Citation Analysis]
326 Rodriguez IJ, Chamucero Millares J, Lalinde Ruiz N, Llano León M, Martínez Enríquez L, Montilla Velásquez MDP, Rodríguez Bohórquez OM, Velandia Vargas EA, Parra López CA. Human immune response to SARS-CoV-2: What is known? A scoping review. Infect 2020;24:26. [DOI: 10.22354/in.v24i3.898] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
327 Saha A, Sharma AR, Bhattacharya M, Sharma G, Lee SS, Chakraborty C. Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More. Arch Med Res. 2020;51:585-586. [PMID: 32439198 DOI: 10.1016/j.arcmed.2020.05.001] [Cited by in Crossref: 84] [Cited by in F6Publishing: 90] [Article Influence: 42.0] [Reference Citation Analysis]
328 Islam H, Rahman A, Masud J, Shweta DS, Araf Y, Ullah MA, Sium SMA, Sarkar B. A Generalized Overview of SARS-CoV-2: Where Does the Current Knowledge Stand? Electron J Gen Med 2020;17:em251. [DOI: 10.29333/ejgm/8258] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
329 Wang C, Zhang J, Lu Z, Wang J, Fang Y, Wang Y, Chen X, Hong N, Jing X. Correlation analysis of risk factors and GSI score of a medical team assisting Wuhan city during the epidemic of COVID-19 in China -A cohort study.. [DOI: 10.1101/2020.04.27.20070466] [Reference Citation Analysis]
330 Acter T, Uddin N, Das J, Akhter A, Choudhury TR, Kim S. Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency. Sci Total Environ 2020;730:138996. [PMID: 32371230 DOI: 10.1016/j.scitotenv.2020.138996] [Cited by in Crossref: 224] [Cited by in F6Publishing: 233] [Article Influence: 112.0] [Reference Citation Analysis]
331 Paital B. Nurture to nature via COVID-19, a self-regenerating environmental strategy of environment in global context. Sci Total Environ 2020;729:139088. [PMID: 32388136 DOI: 10.1016/j.scitotenv.2020.139088] [Cited by in Crossref: 105] [Cited by in F6Publishing: 108] [Article Influence: 52.5] [Reference Citation Analysis]
332 maraghi E, Malehi AS, Rahim F. Global health security capacity against COVID-19 outbreak and its association with the case fatality rate: an analysis of annual data from 210 countries and territories.. [DOI: 10.1101/2020.04.25.20079186] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
333 Li W, Chen X. The nexus of travel restriction, air pollution and COVID-19 infection: Investigation from a megacity of the southern China.. [DOI: 10.1101/2020.04.25.20079335] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
334 Iyer M, Jayaramayya K, Subramaniam MD, Lee SB, Dayem AA, Cho SG, Vellingiri B. COVID-19: an update on diagnostic and therapeutic approaches. BMB Rep 2020;53:191-205. [PMID: 32336317 [PMID: 32336317 DOI: 10.5483/bmbrep.2020.53.4.080] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 28.0] [Reference Citation Analysis]
335 Balachandar V, Mahalaxmi I, Subramaniam M, Kaavya J, Senthil Kumar N, Laldinmawii G, Narayanasamy A, Janardhana Kumar Reddy P, Sivaprakash P, Kanchana S, Vivekanandhan G, Cho SG. Follow-up studies in COVID-19 recovered patients - is it mandatory? Sci Total Environ 2020;729:139021. [PMID: 32360909 DOI: 10.1016/j.scitotenv.2020.139021] [Cited by in Crossref: 81] [Cited by in F6Publishing: 86] [Article Influence: 40.5] [Reference Citation Analysis]
336 Paital B, Das K, Parida SK. Inter nation social lockdown versus medical care against COVID-19, a mild environmental insight with special reference to India. Sci Total Environ 2020;728:138914. [PMID: 32339832 DOI: 10.1016/j.scitotenv.2020.138914] [Cited by in Crossref: 135] [Cited by in F6Publishing: 107] [Article Influence: 67.5] [Reference Citation Analysis]
337 Nikhat S, Fazil M. Overview of Covid-19; its prevention and management in the light of Unani medicine. Sci Total Environ 2020;728:138859. [PMID: 32334163 DOI: 10.1016/j.scitotenv.2020.138859] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 21.0] [Reference Citation Analysis]
338 Briz-Redón Á, Serrano-Aroca Á. A spatio-temporal analysis for exploring the effect of temperature on COVID-19 early evolution in Spain. Sci Total Environ 2020;728:138811. [PMID: 32361118 DOI: 10.1016/j.scitotenv.2020.138811] [Cited by in Crossref: 182] [Cited by in F6Publishing: 140] [Article Influence: 91.0] [Reference Citation Analysis]
339 Tomar A, Gupta N. Prediction for the spread of COVID-19 in India and effectiveness of preventive measures. Sci Total Environ 2020;728:138762. [PMID: 32334157 DOI: 10.1016/j.scitotenv.2020.138762] [Cited by in Crossref: 255] [Cited by in F6Publishing: 268] [Article Influence: 127.5] [Reference Citation Analysis]
340 Shawky E, Nada AA, Ibrahim RS. Potential role of medicinal plants and their constituents in the mitigation of SARS-CoV-2: identifying related therapeutic targets using network pharmacology and molecular docking analyses. RSC Adv 2020;10:27961-83. [DOI: 10.1039/d0ra05126h] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 15.5] [Reference Citation Analysis]
341 Chumachenko D, Chumachenko T, Meniailov I, Pyrohov P, Kuzin I, Rodyna R. On-Line Data Processing, Simulation and Forecasting of the Coronavirus Disease (COVID-19) Propagation in Ukraine Based on Machine Learning Approach. Communications in Computer and Information Science 2020. [DOI: 10.1007/978-3-030-61656-4_25] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
342 Asongu S, Usman U. The COVID-19 Pandemic: Theoretical and Practical Perspectives on Children, Women and Sex Trafficking. SSRN Journal. [DOI: 10.2139/ssrn.3726615] [Reference Citation Analysis]
343 Sharma GD, Mahendru M. Lives or livelihood: Insights from locked-down India due to COVID19. Soc Sci Humanit Open 2020;2:100036. [PMID: 34171024 DOI: 10.1016/j.ssaho.2020.100036] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
344 Ghosh A, Nundy S, Mallick TK. How India is dealing with COVID-19 pandemic. Sensors International 2020;1:100021. [DOI: 10.1016/j.sintl.2020.100021] [Cited by in Crossref: 73] [Cited by in F6Publishing: 36] [Article Influence: 36.5] [Reference Citation Analysis]
345 Abbasinazari M. Possible role of zinc (Zn) as an adjunctive therapy in gastrointestinal symptoms of COVID-19 infectious disease. Gastroenterol Hepatol Bed Bench 2020;13:417-8. [PMID: 33244389] [Reference Citation Analysis]
346 Khurana A. COVID-19: What lies ahead for Homoeopathy? Indian J Res Homoeopathy 2020;14:169. [DOI: 10.4103/ijrh.ijrh_92_20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
347 [DOI: 10.1101/2020.11.16.386003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]